| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | FSTL4 DYSF F7 SVEP1 PCDH17 CABYR FAT2 PCDH19 LTBP4 HSPA5 PCDHGA11 FAT3 ITSN1 PCDHB15 CAPNS1 PCDHB13 PCDHB10 PCDHB9 CAPNS2 PCDHB3 PCDHAC2 CRTAC1 CDH19 PCDHB16 EYS NKD1 CELSR2 PADI6 PCDHGC3 CDH10 | 6.31e-10 | 749 | 216 | 30 | GO:0005509 |
| GeneOntologyMolecularFunction | acetylcholine receptor regulator activity | 3.66e-07 | 27 | 216 | 6 | GO:0030548 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor regulator activity | 4.62e-07 | 28 | 216 | 6 | GO:0099602 | |
| GeneOntologyMolecularFunction | translation activator activity | 1.66e-05 | 15 | 216 | 4 | GO:0008494 | |
| GeneOntologyMolecularFunction | protein kinase binding | CADM4 SHC3 SPDYE11 BMPR2 SPDYE15 PKD1 SPDYE21 SPDYE5 SPDYE2B SPDYE14 CACNB1 SPDYE17 SPDYE10 ANK2 ZBTB4 APC CEP192 SPDYE12 EGFR SPDYE2 SPDYE8 SPDYE6 TP73 | 7.72e-05 | 873 | 216 | 23 | GO:0019901 |
| GeneOntologyMolecularFunction | histone phosphatase activity | 3.47e-04 | 3 | 216 | 2 | GO:0140789 | |
| GeneOntologyMolecularFunction | histone H2AXY142 phosphatase activity | 3.47e-04 | 3 | 216 | 2 | GO:0140793 | |
| GeneOntologyMolecularFunction | kinase binding | CADM4 SHC3 SPDYE11 BMPR2 SPDYE15 PKD1 SPDYE21 SPDYE5 SPDYE2B SPDYE14 CACNB1 SPDYE17 SPDYE10 ANK2 ZBTB4 APC CEP192 SPDYE12 EGFR SPDYE2 SPDYE8 SPDYE6 TP73 | 3.51e-04 | 969 | 216 | 23 | GO:0019900 |
| GeneOntologyMolecularFunction | glucosidase activity | 5.16e-04 | 15 | 216 | 3 | GO:0015926 | |
| GeneOntologyMolecularFunction | protein domain specific binding | PAG1 HIVEP1 LILRB1 NEDD4 CABYR SPON1 PKD1 ABCC2 LNX1 HSPA5 CARD14 CACNB1 POLR2J3 TACC2 EBF1 BHLHE40 NKD1 NPTXR TP63 CNTNAP2 TP53BP2 | 5.54e-04 | 875 | 216 | 21 | GO:0019904 |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 8.94e-04 | 103 | 216 | 6 | GO:0004553 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CADM4 PCDH17 FAT2 PCDH19 NECTIN1 PKD1 SDK1 SDK2 PCDHGA11 FAT3 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 CDH19 PCDHB16 CELSR2 PCDHGC3 CDH10 | 2.09e-16 | 187 | 204 | 21 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CADM4 PCDH17 FAT2 PCDH19 NECTIN1 PKD1 FLRT3 SDK1 SDK2 PCDHGA11 FAT3 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 CDH19 PCDHB16 CELSR2 PCDHGC3 CDH10 | 6.85e-13 | 313 | 204 | 22 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell junction organization | PSEN2 ITGA6 CHRNA1 SVEP1 PCDH17 NEDD4 NFATC4 NECTIN1 FLRT3 BSN LNX1 SDK1 CACNB1 SDK2 FN1 ANK2 ITSN1 PCDHB13 PCDHB10 PCDHB9 PCDHB3 APC LAMC1 CRTAC1 CDH19 ZNF365 PCDHB16 NPTXR CNTNAP2 GRIP2 PARD3 TNS1 PCDHGC3 CDH10 | 1.32e-10 | 974 | 204 | 34 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell junction assembly | ITGA6 PCDH17 NECTIN1 FLRT3 BSN SDK1 SDK2 FN1 ANK2 PCDHB13 PCDHB10 PCDHB9 PCDHB3 APC LAMC1 CRTAC1 CDH19 PCDHB16 NPTXR CNTNAP2 PARD3 TNS1 CDH10 | 1.19e-08 | 569 | 204 | 23 | GO:0034329 |
| GeneOntologyBiologicalProcess | synapse organization | PSEN2 CHRNA1 PCDH17 NEDD4 NFATC4 NECTIN1 FLRT3 BSN LNX1 SDK1 CACNB1 SDK2 ITSN1 PCDHB13 PCDHB10 PCDHB9 PCDHB3 CRTAC1 ZNF365 PCDHB16 NPTXR CNTNAP2 GRIP2 PCDHGC3 CDH10 | 1.99e-08 | 685 | 204 | 25 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | PAG1 CADM4 ITGA6 UBASH3A LILRB1 SVEP1 PCDH17 NEO1 FAT2 GLI3 PCDH19 NECTIN1 PKD1 FLRT3 SDK1 SDK2 PCDHGA11 FAT3 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 CDH19 PCDHB16 CELSR2 EGFR LRP6 PARD3 PCDHGC3 CDH10 | 2.43e-08 | 1077 | 204 | 32 | GO:0098609 |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 4.83e-08 | 53 | 204 | 8 | GO:0016339 | |
| GeneOntologyBiologicalProcess | female meiosis II | 1.37e-07 | 6 | 204 | 4 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 1.37e-07 | 6 | 204 | 4 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 1.37e-07 | 6 | 204 | 4 | GO:0061983 | |
| GeneOntologyBiologicalProcess | synapse assembly | PCDH17 NECTIN1 FLRT3 BSN SDK1 SDK2 PCDHB13 PCDHB10 PCDHB9 PCDHB3 CRTAC1 PCDHB16 NPTXR CNTNAP2 | 2.52e-06 | 308 | 204 | 14 | GO:0007416 |
| GeneOntologyBiologicalProcess | neuron projection development | FSTL4 ITGA6 NEDD4 BMPR2 NEO1 FIG4 NFATC4 GLI3 NECTIN1 FLRT3 HERC1 SDK1 HSPA5 PLXNA1 SEMA6C FN1 FAT3 ITSN1 APC ARFGEF1 PCDHAC2 ISL2 LAMC1 CRTAC1 ZNF365 CELSR2 EGFR NPTXR CNTNAP2 LRP6 PARD3 | 3.68e-06 | 1285 | 204 | 31 | GO:0031175 |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein serine/threonine kinase activity | 4.08e-06 | 25 | 204 | 5 | GO:0045737 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 5.01e-06 | 26 | 204 | 5 | GO:0045836 | |
| GeneOntologyBiologicalProcess | anterior/posterior pattern specification | PSEN2 HOXA7 BMPR2 HOXC6 GLI3 APC BHLHE40 NKD1 CELSR2 ATP6AP2 OSR1 LRP6 | 6.84e-06 | 247 | 204 | 12 | GO:0009952 |
| GeneOntologyBiologicalProcess | neuron development | FSTL4 ITGA6 NEDD4 BMPR2 NEO1 FIG4 NFATC4 GLI3 NECTIN1 FLRT3 HERC1 SDK1 HSPA5 PLXNA1 SEMA6C FN1 FAT3 ITSN1 APC ARFGEF1 PCDHAC2 ISL2 LAMC1 CRTAC1 ZNF365 CELSR2 EGFR NPTXR CNTNAP2 LRP6 GRIP2 PARD3 TP73 | 7.15e-06 | 1463 | 204 | 33 | GO:0048666 |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein kinase activity | 7.36e-06 | 28 | 204 | 5 | GO:1904031 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 1.24e-05 | 31 | 204 | 5 | GO:0070935 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | PSEN2 DYSF LILRB1 CHRNA1 SHC3 PCDH17 NEDD4 NEO1 PTPRN2 NFATC4 BSN TENT2 CACNB1 NPTX2 HTR1B PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHB16 EGFR CNTNAP2 LRP6 GRIP2 | 1.77e-05 | 931 | 204 | 24 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | PSEN2 DYSF LILRB1 CHRNA1 SHC3 PCDH17 NEDD4 NEO1 PTPRN2 NFATC4 BSN TENT2 CACNB1 NPTX2 HTR1B PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHB16 EGFR CNTNAP2 LRP6 GRIP2 | 1.77e-05 | 931 | 204 | 24 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | PSEN2 DYSF LILRB1 CHRNA1 SHC3 PCDH17 NEDD4 NEO1 PTPRN2 NFATC4 BSN TENT2 CACNB1 NPTX2 HTR1B PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHB16 EGFR CNTNAP2 LRP6 GRIP2 | 2.04e-05 | 939 | 204 | 24 | GO:0099537 |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 3.04e-05 | 37 | 204 | 5 | GO:0051446 | |
| GeneOntologyBiologicalProcess | synaptic signaling | PSEN2 DYSF LILRB1 CHRNA1 SHC3 PCDH17 NEDD4 NEO1 PTPRN2 NFATC4 BSN TENT2 CACNB1 NPTX2 HTR1B PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHB16 EGFR CNTNAP2 LRP6 GRIP2 | 3.78e-05 | 976 | 204 | 24 | GO:0099536 |
| GeneOntologyBiologicalProcess | regulation of cyclin-dependent protein serine/threonine kinase activity | 4.73e-05 | 96 | 204 | 7 | GO:0000079 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | FSTL4 NEDD4 BMPR2 NEO1 NFATC4 GLI3 NECTIN1 FLRT3 PLXNA1 SEMA6C FN1 FAT3 APC PCDHAC2 ISL2 LAMC1 ZNF365 CELSR2 CNTNAP2 PARD3 | 5.61e-05 | 748 | 204 | 20 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of cyclin-dependent protein kinase activity | 6.15e-05 | 100 | 204 | 7 | GO:1904029 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 6.55e-05 | 101 | 204 | 7 | GO:1902369 | |
| GeneOntologyBiologicalProcess | heart development | TRAF3IP2 EYA1 NEDD4 BMPR2 NFATC4 GLI3 PKD1 FLRT3 DNAH5 FN1 ANK2 KAT6A APC EGFR OSR1 LRP6 MYOCD GAA TP53BP2 TP73 | 6.61e-05 | 757 | 204 | 20 | GO:0007507 |
| GeneOntologyBiologicalProcess | pattern specification process | PSEN2 EYA1 HOXA7 BMPR2 HOXC6 GLI3 DNAH5 APC BHLHE40 NKD1 CELSR2 ATP6AP2 TP63 OSR1 LRP6 FUT6 | 7.32e-05 | 526 | 204 | 16 | GO:0007389 |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 7.98e-05 | 45 | 204 | 5 | GO:0040020 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 1.15e-04 | 77 | 204 | 6 | GO:0048255 | |
| GeneOntologyBiologicalProcess | odontogenesis | 1.32e-04 | 151 | 204 | 8 | GO:0042476 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | FSTL4 NEDD4 BMPR2 NEO1 NFATC4 GLI3 NECTIN1 FLRT3 PLXNA1 SEMA6C FN1 APC PCDHAC2 ISL2 LAMC1 ZNF365 CELSR2 EGFR CNTNAP2 PARD3 | 1.44e-04 | 802 | 204 | 20 | GO:0048812 |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 1.48e-04 | 115 | 204 | 7 | GO:1903312 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 1.82e-04 | 29 | 204 | 4 | GO:0045948 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | FSTL4 NEDD4 BMPR2 NEO1 NFATC4 GLI3 NECTIN1 FLRT3 PLXNA1 SEMA6C FN1 APC PCDHAC2 ISL2 LAMC1 ZNF365 CELSR2 EGFR CNTNAP2 PARD3 | 1.90e-04 | 819 | 204 | 20 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | FSTL4 NEDD4 BMPR2 NEO1 NFATC4 GLI3 NECTIN1 FLRT3 PLXNA1 SEMA6C FN1 APC PCDHAC2 ISL2 LAMC1 ZNF365 CELSR2 EGFR CNTNAP2 PARD3 | 2.13e-04 | 826 | 204 | 20 | GO:0048858 |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | ANKRD31 DAZ1 SPDYE5 DAZ3 DAZ2 SPDYE2B DAZ4 EGFR TP63 SPDYE2 LRP6 EIF4G3 SPDYE6 | 2.19e-04 | 407 | 204 | 13 | GO:0045787 |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 2.26e-04 | 87 | 204 | 6 | GO:1902373 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 2.40e-04 | 88 | 204 | 6 | GO:0043489 | |
| GeneOntologyBiologicalProcess | regionalization | PSEN2 HOXA7 BMPR2 HOXC6 GLI3 DNAH5 APC BHLHE40 NKD1 CELSR2 ATP6AP2 TP63 OSR1 LRP6 | 3.05e-04 | 478 | 204 | 14 | GO:0003002 |
| GeneOntologyBiologicalProcess | cerebellum morphogenesis | 3.16e-04 | 60 | 204 | 5 | GO:0021587 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | CDC42EP4 FSTL4 NEDD4 BMPR2 NEO1 NFATC4 GLI3 NECTIN1 FLRT3 PLXNA1 SEMA6C FN1 FAT3 APC PCDHAC2 ISL2 LAMC1 CDH19 ZNF365 CELSR2 EGFR CNTNAP2 LRP6 PARD3 CDH10 | 3.24e-04 | 1194 | 204 | 25 | GO:0000902 |
| GeneOntologyBiologicalProcess | skin morphogenesis | 3.97e-04 | 15 | 204 | 3 | GO:0043589 | |
| GeneOntologyBiologicalProcess | hindbrain morphogenesis | 4.28e-04 | 64 | 204 | 5 | GO:0021575 | |
| GeneOntologyBiologicalProcess | developmental maturation | PSEN2 DAZ1 CABYR NFATC4 DAZ3 DAZ2 LNX1 HOXB13 DAZ4 ATP6AP2 CNTNAP2 GRIP2 FUT6 | 4.51e-04 | 439 | 204 | 13 | GO:0021700 |
| GeneOntologyBiologicalProcess | proximal/distal pattern formation | 4.75e-04 | 37 | 204 | 4 | GO:0009954 | |
| GeneOntologyBiologicalProcess | oligosaccharide catabolic process | 4.85e-04 | 16 | 204 | 3 | GO:0009313 | |
| GeneOntologyBiologicalProcess | axonogenesis | FSTL4 BMPR2 NEO1 GLI3 NECTIN1 FLRT3 PLXNA1 SEMA6C FN1 APC PCDHAC2 ISL2 LAMC1 CNTNAP2 PARD3 | 5.34e-04 | 566 | 204 | 15 | GO:0007409 |
| GeneOntologyBiologicalProcess | cerebrospinal fluid secretion | 5.76e-04 | 4 | 204 | 2 | GO:0033326 | |
| GeneOntologyBiologicalProcess | calcium-independent cell-matrix adhesion | 5.76e-04 | 4 | 204 | 2 | GO:0007161 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | BMPR2 NEO1 GLI3 NECTIN1 FLRT3 PLXNA1 SEMA6C PCDHAC2 ISL2 LAMC1 | 5.84e-04 | 286 | 204 | 10 | GO:0097485 |
| GeneOntologyBiologicalProcess | oligosaccharide metabolic process | 6.48e-04 | 70 | 204 | 5 | GO:0009311 | |
| GeneOntologyBiologicalProcess | axon development | FSTL4 BMPR2 NEO1 GLI3 NECTIN1 FLRT3 PLXNA1 SEMA6C FN1 APC PCDHAC2 ISL2 LAMC1 CRTAC1 CNTNAP2 PARD3 | 6.79e-04 | 642 | 204 | 16 | GO:0061564 |
| GeneOntologyBiologicalProcess | odontogenesis of dentin-containing tooth | 6.86e-04 | 107 | 204 | 6 | GO:0042475 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | PSEN2 BCAS3 EYA1 DYSF BMPR2 PHLDB1 NEO1 PTPRB PXDN FIG4 NFATC4 GLI3 NECTIN1 PKD1 HERC1 SDK1 PLXNA1 SDK2 FN1 ANK2 FAT3 SOX30 NKD1 CSF3R RTL1 TP63 OSR1 LRP6 | 7.30e-04 | 1483 | 204 | 28 | GO:0048646 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | PSEN2 ITGA6 EYA1 NEDD4 HOXA7 BMPR2 GLI3 NECTIN1 PKD1 USH2A SDK1 HOXB13 PLXNA1 SDK2 FAT3 KAT6A APC LAMC1 NKD1 CSF3R EGFR TP63 OSR1 LRP6 GAA | 7.87e-04 | 1269 | 204 | 25 | GO:0009887 |
| MousePheno | embryonic lethality, incomplete penetrance | BCAS3 BMPR2 GLI3 PKD1 FLRT3 ALPI ALPG FN1 CAPNS1 APC LAMC1 VIRMA EGFR AIFM1 TP63 OSR1 LRP6 | 9.76e-06 | 410 | 169 | 17 | MP:0011102 |
| MousePheno | prenatal lethality prior to heart atrial septation, incomplete penetrance | BCAS3 BMPR2 GLI3 PKD1 FLRT3 ALPI ALPG FN1 CAPNS1 APC LAMC1 VIRMA EGFR AIFM1 TP63 OSR1 LRP6 | 9.76e-06 | 410 | 169 | 17 | MP:0031660 |
| Domain | Cadherin_CS | PCDH17 FAT2 PCDH19 PCDHGA11 FAT3 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 CDH19 PCDHB16 CELSR2 PCDHGC3 CDH10 | 6.97e-14 | 109 | 207 | 16 | IPR020894 |
| Domain | CADHERIN_1 | PCDH17 FAT2 PCDH19 PCDHGA11 FAT3 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 CDH19 PCDHB16 CELSR2 PCDHGC3 CDH10 | 1.25e-13 | 113 | 207 | 16 | PS00232 |
| Domain | Cadherin | PCDH17 FAT2 PCDH19 PCDHGA11 FAT3 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 CDH19 PCDHB16 CELSR2 PCDHGC3 CDH10 | 1.25e-13 | 113 | 207 | 16 | PF00028 |
| Domain | CADHERIN_2 | PCDH17 FAT2 PCDH19 PCDHGA11 FAT3 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 CDH19 PCDHB16 CELSR2 PCDHGC3 CDH10 | 1.44e-13 | 114 | 207 | 16 | PS50268 |
| Domain | - | PCDH17 FAT2 PCDH19 PCDHGA11 FAT3 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 CDH19 PCDHB16 CELSR2 PCDHGC3 CDH10 | 1.44e-13 | 114 | 207 | 16 | 2.60.40.60 |
| Domain | CA | PCDH17 FAT2 PCDH19 PCDHGA11 FAT3 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 CDH19 PCDHB16 CELSR2 PCDHGC3 CDH10 | 1.65e-13 | 115 | 207 | 16 | SM00112 |
| Domain | Cadherin-like | PCDH17 FAT2 PCDH19 PCDHGA11 FAT3 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 CDH19 PCDHB16 CELSR2 PCDHGC3 CDH10 | 1.90e-13 | 116 | 207 | 16 | IPR015919 |
| Domain | Cadherin | PCDH17 FAT2 PCDH19 PCDHGA11 FAT3 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 CDH19 PCDHB16 CELSR2 PCDHGC3 CDH10 | 2.50e-13 | 118 | 207 | 16 | IPR002126 |
| Domain | Cadherin_2 | PCDH17 PCDH19 PCDHGA11 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 PCDHB16 PCDHGC3 | 1.26e-10 | 65 | 207 | 11 | PF08266 |
| Domain | Cadherin_N | PCDH17 PCDH19 PCDHGA11 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 PCDHB16 PCDHGC3 | 1.26e-10 | 65 | 207 | 11 | IPR013164 |
| Domain | Cadherin_C | PCDHGA11 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 PCDHB16 PCDHGC3 | 6.89e-10 | 42 | 207 | 9 | IPR032455 |
| Domain | Cadherin_C_2 | PCDHGA11 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 PCDHB16 PCDHGC3 | 6.89e-10 | 42 | 207 | 9 | PF16492 |
| Domain | Spy1 | 6.97e-08 | 11 | 207 | 5 | PF11357 | |
| Domain | Speedy | 6.97e-08 | 11 | 207 | 5 | IPR020984 | |
| Domain | - | 1.09e-06 | 95 | 207 | 9 | 2.60.120.200 | |
| Domain | LAM_G_DOMAIN | 3.54e-06 | 38 | 207 | 6 | PS50025 | |
| Domain | Laminin_G_2 | 4.83e-06 | 40 | 207 | 6 | PF02210 | |
| Domain | EGF_1 | F7 SVEP1 FAT2 USH2A LTBP4 FN1 FAT3 LAMC1 CRTAC1 EYS CELSR2 CNTNAP2 LRP6 | 5.66e-06 | 255 | 207 | 13 | PS00022 |
| Domain | LamG | 8.57e-06 | 44 | 207 | 6 | SM00282 | |
| Domain | EGF-like_CS | F7 SVEP1 FAT2 LTBP4 FN1 FAT3 LAMC1 CRTAC1 EYS CELSR2 CNTNAP2 LRP6 | 3.62e-05 | 261 | 207 | 12 | IPR013032 |
| Domain | Laminin_G | 4.32e-05 | 58 | 207 | 6 | IPR001791 | |
| Domain | - | A1BG CADM4 FSTL4 ISLR LILRB1 NEO1 PTPRB PXDN NFATC4 NECTIN1 FLRT3 USH2A SDK1 PLXNA1 SDK2 FN1 EBF1 PKHD1L1 SIGLEC7 CSF3R | 5.07e-05 | 663 | 207 | 20 | 2.60.40.10 |
| Domain | EGF_CA | 6.50e-05 | 122 | 207 | 8 | SM00179 | |
| Domain | IGc2 | A1BG CADM4 FSTL4 ISLR LILRB1 NEO1 PXDN NECTIN1 SDK1 SDK2 SIGLEC7 | 6.52e-05 | 235 | 207 | 11 | SM00408 |
| Domain | Ig_sub2 | A1BG CADM4 FSTL4 ISLR LILRB1 NEO1 PXDN NECTIN1 SDK1 SDK2 SIGLEC7 | 6.52e-05 | 235 | 207 | 11 | IPR003598 |
| Domain | EGF-like_Ca-bd_dom | 7.29e-05 | 124 | 207 | 8 | IPR001881 | |
| Domain | EGF-like_dom | F7 SVEP1 FAT2 LTBP4 FAT3 LAMC1 CRTAC1 EYS CELSR2 CNTNAP2 LRP6 | 1.09e-04 | 249 | 207 | 11 | IPR000742 |
| Domain | Ig-like_fold | A1BG CADM4 FSTL4 ISLR LILRB1 NEO1 PTPRB PXDN NFATC4 NECTIN1 FLRT3 USH2A SDK1 PLXNA1 SDK2 FN1 EBF1 PKHD1L1 SIGLEC7 CSF3R | 1.19e-04 | 706 | 207 | 20 | IPR013783 |
| Domain | PTX | 1.52e-04 | 10 | 207 | 3 | SM00159 | |
| Domain | ConA-like_dom | 1.72e-04 | 219 | 207 | 10 | IPR013320 | |
| Domain | EGF_2 | F7 SVEP1 FAT2 LTBP4 FAT3 LAMC1 CRTAC1 EYS CELSR2 CNTNAP2 LRP6 | 1.88e-04 | 265 | 207 | 11 | PS01186 |
| Domain | Pentaxin-related | 2.07e-04 | 11 | 207 | 3 | IPR001759 | |
| Domain | Pentaxin | 2.07e-04 | 11 | 207 | 3 | PF00354 | |
| Domain | HECT | 2.11e-04 | 27 | 207 | 4 | PF00632 | |
| Domain | HECTc | 2.11e-04 | 27 | 207 | 4 | SM00119 | |
| Domain | HECT_dom | 2.11e-04 | 27 | 207 | 4 | IPR000569 | |
| Domain | IPT | 2.11e-04 | 27 | 207 | 4 | SM00429 | |
| Domain | HECT | 2.11e-04 | 27 | 207 | 4 | PS50237 | |
| Domain | EGF | 3.03e-04 | 235 | 207 | 10 | SM00181 | |
| Domain | EGF_3 | 3.03e-04 | 235 | 207 | 10 | PS50026 | |
| Domain | P53 | 3.64e-04 | 3 | 207 | 2 | PF00870 | |
| Domain | P53 | 3.64e-04 | 3 | 207 | 2 | PS00348 | |
| Domain | p53_DNA-bd | 3.64e-04 | 3 | 207 | 2 | IPR011615 | |
| Domain | p53_tetrameristn | 3.64e-04 | 3 | 207 | 2 | IPR010991 | |
| Domain | p53_tumour_suppressor | 3.64e-04 | 3 | 207 | 2 | IPR002117 | |
| Domain | - | 3.64e-04 | 3 | 207 | 2 | 4.10.170.10 | |
| Domain | P53_tetramer | 3.64e-04 | 3 | 207 | 2 | PF07710 | |
| Domain | TIG | 3.65e-04 | 31 | 207 | 4 | PF01833 | |
| Domain | IPT | 4.13e-04 | 32 | 207 | 4 | IPR002909 | |
| Domain | fn3 | 4.57e-04 | 162 | 207 | 8 | PF00041 | |
| Domain | EGF | 5.15e-04 | 126 | 207 | 7 | PF00008 | |
| Domain | Alk_phosphatase | 7.23e-04 | 4 | 207 | 2 | PF00245 | |
| Domain | Alkaline_phosphatase_AS | 7.23e-04 | 4 | 207 | 2 | IPR018299 | |
| Domain | EYA_dom | 7.23e-04 | 4 | 207 | 2 | IPR006545 | |
| Domain | RNA_POL_L_13KD | 7.23e-04 | 4 | 207 | 2 | PS01154 | |
| Domain | RNA_pol_Rpb11_13-16kDa_CS | 7.23e-04 | 4 | 207 | 2 | IPR008193 | |
| Domain | Alkaline_phosphatase | 7.23e-04 | 4 | 207 | 2 | IPR001952 | |
| Domain | EYA_fam | 7.23e-04 | 4 | 207 | 2 | IPR028472 | |
| Domain | alkPPc | 7.23e-04 | 4 | 207 | 2 | SM00098 | |
| Domain | ALKALINE_PHOSPHATASE | 7.23e-04 | 4 | 207 | 2 | PS00123 | |
| Domain | EGF_Ca-bd_CS | 7.37e-04 | 97 | 207 | 6 | IPR018097 | |
| Domain | Gal_mutarotase_SF_dom | 8.14e-04 | 17 | 207 | 3 | IPR011013 | |
| Domain | EGF_CA | 8.21e-04 | 99 | 207 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 8.65e-04 | 100 | 207 | 6 | PS00010 | |
| Domain | FN3 | 1.09e-03 | 185 | 207 | 8 | SM00060 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.17e-03 | 106 | 207 | 6 | IPR000152 | |
| Domain | Glyco_hydro_38_C | 1.20e-03 | 5 | 207 | 2 | IPR011682 | |
| Domain | GLYCOSYL_HYDROL_F31_2 | 1.20e-03 | 5 | 207 | 2 | PS00707 | |
| Domain | Alpha-mann_mid | 1.20e-03 | 5 | 207 | 2 | PF09261 | |
| Domain | Glyco_hydro_57/38_cen | 1.20e-03 | 5 | 207 | 2 | IPR028995 | |
| Domain | Glyco_hydro_38 | 1.20e-03 | 5 | 207 | 2 | PF01074 | |
| Domain | - | 1.20e-03 | 5 | 207 | 2 | 1.20.1270.50 | |
| Domain | - | 1.20e-03 | 5 | 207 | 2 | 3.20.110.10 | |
| Domain | Alpha-mann_mid | 1.20e-03 | 5 | 207 | 2 | SM00872 | |
| Domain | Glyco_hydro_38_N | 1.20e-03 | 5 | 207 | 2 | IPR000602 | |
| Domain | Glyco_hydro_38/57_N | 1.20e-03 | 5 | 207 | 2 | IPR027291 | |
| Domain | Glyco_hydro_38_cen | 1.20e-03 | 5 | 207 | 2 | IPR015341 | |
| Domain | Glyco_hydro_38C | 1.20e-03 | 5 | 207 | 2 | PF07748 | |
| Domain | Ig_I-set | 1.29e-03 | 190 | 207 | 8 | IPR013098 | |
| Domain | I-set | 1.29e-03 | 190 | 207 | 8 | PF07679 | |
| Domain | FN3 | 1.73e-03 | 199 | 207 | 8 | PS50853 | |
| Domain | SEFIR | 1.78e-03 | 6 | 207 | 2 | PF08357 | |
| Domain | p53/RUNT-type_TF_DNA-bd | 1.78e-03 | 6 | 207 | 2 | IPR012346 | |
| Domain | - | 1.78e-03 | 6 | 207 | 2 | 2.60.40.720 | |
| Domain | SEFIR_dom | 1.78e-03 | 6 | 207 | 2 | IPR013568 | |
| Domain | RBP11-like_dimer | 1.78e-03 | 6 | 207 | 2 | IPR009025 | |
| Domain | SEFIR | 1.78e-03 | 6 | 207 | 2 | PS51534 | |
| Domain | RNA_pol_L | 1.78e-03 | 6 | 207 | 2 | PF01193 | |
| Domain | Growth_fac_rcpt_ | 1.80e-03 | 156 | 207 | 7 | IPR009030 | |
| Domain | FN3_dom | 2.35e-03 | 209 | 207 | 8 | IPR003961 | |
| Domain | Glyco_hydro_31 | 2.47e-03 | 7 | 207 | 2 | IPR000322 | |
| Domain | Glyco_hydro_31 | 2.47e-03 | 7 | 207 | 2 | PF01055 | |
| Domain | Glyco_hydro/deAcase_b/a-brl | 2.47e-03 | 7 | 207 | 2 | IPR011330 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 2.47e-03 | 7 | 207 | 2 | PS00129 | |
| Domain | p53-like_TF_DNA-bd | 2.81e-03 | 53 | 207 | 4 | IPR008967 | |
| Domain | hEGF | 3.58e-03 | 28 | 207 | 3 | PF12661 | |
| Pubmed | PCDH17 FAT2 PCDHGA11 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 PCDHB16 CELSR2 PCDHGC3 | 7.36e-14 | 77 | 219 | 12 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDH17 FAT2 PCDHGA11 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 PCDHB16 CELSR2 PCDHGC3 | 1.19e-13 | 80 | 219 | 12 | 10716726 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | FAT2 PCDHGA11 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 PCDHB16 CELSR2 PCDHGC3 | 1.03e-12 | 72 | 219 | 11 | 10380929 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDH17 PCDHGA11 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 PCDHB16 PCDHGC3 | 4.03e-11 | 74 | 219 | 10 | 10817752 |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | PCDHGA11 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 PCDHB16 PCDHGC3 | 9.14e-11 | 57 | 219 | 9 | 32633719 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SETD1A MAN2B1 VWA8 BCAS3 ARHGEF11 DYSF MYORG TMEM129 PHLDB1 TNRC18 PKD1 CPSF1 HERC2 HERC1 LTBP4 HOXB13 PLXNA1 MED13 SEMA6C SH3RF1 WWP1 KAT6A ZBTB4 CEP192 AATK CELSR2 MTMR14 IL17RE CHD5 | 9.60e-11 | 1105 | 219 | 29 | 35748872 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHGA11 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 PCDHB16 PCDHGC3 | 4.71e-10 | 68 | 219 | 9 | 11230163 |
| Pubmed | 1.53e-09 | 4 | 219 | 4 | 11694340 | ||
| Pubmed | 1.53e-09 | 4 | 219 | 4 | 9321470 | ||
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 1.53e-09 | 4 | 219 | 4 | 26232607 | |
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 1.53e-09 | 4 | 219 | 4 | 11883873 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 1.53e-09 | 4 | 219 | 4 | 16963411 | |
| Pubmed | 1.53e-09 | 4 | 219 | 4 | 7670487 | ||
| Pubmed | 1.53e-09 | 4 | 219 | 4 | 19223287 | ||
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 1.53e-09 | 4 | 219 | 4 | 11688365 | |
| Pubmed | 1.53e-09 | 4 | 219 | 4 | 12752250 | ||
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 1.53e-09 | 4 | 219 | 4 | 12801575 | |
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 1.53e-09 | 4 | 219 | 4 | 15066457 | |
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 1.53e-09 | 4 | 219 | 4 | 11095434 | |
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 1.53e-09 | 4 | 219 | 4 | 10936047 | |
| Pubmed | 2.10e-09 | 20 | 219 | 6 | 11322959 | ||
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 PCDHB16 PCDHGC3 | 3.18e-09 | 58 | 219 | 8 | 30377227 |
| Pubmed | Licensing of primordial germ cells for gametogenesis depends on genital ridge signaling. | 7.23e-09 | 12 | 219 | 5 | 25739037 | |
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 23579190 | ||
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 22293198 | ||
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 11089564 | ||
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 7.61e-09 | 5 | 219 | 4 | 10393944 | |
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 7.61e-09 | 5 | 219 | 4 | 30380414 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 7.61e-09 | 5 | 219 | 4 | 26411291 | |
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 8896558 | ||
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 7.61e-09 | 5 | 219 | 4 | 22021443 | |
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 7.61e-09 | 5 | 219 | 4 | 10903443 | |
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 9143498 | ||
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 7.61e-09 | 5 | 219 | 4 | 19783541 | |
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 17761180 | ||
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 23298641 | ||
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 7.61e-09 | 5 | 219 | 4 | 23223451 | |
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 11804965 | ||
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 8661148 | ||
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 20008336 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 7.61e-09 | 5 | 219 | 4 | 8679003 | |
| Pubmed | AZFc partial deletions in Chilean men with severe spermatogenic failure. | 7.61e-09 | 5 | 219 | 4 | 17416365 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 7.61e-09 | 5 | 219 | 4 | 8968756 | |
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 8968755 | ||
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 34985827 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 7.61e-09 | 5 | 219 | 4 | 14648873 | |
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 9700189 | ||
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 7.61e-09 | 5 | 219 | 4 | 9288969 | |
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 23456578 | ||
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 7.61e-09 | 5 | 219 | 4 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 7.61e-09 | 5 | 219 | 4 | 8845845 | |
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 11058556 | ||
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 19468308 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 7.61e-09 | 5 | 219 | 4 | 12200456 | |
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 11514340 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 7.61e-09 | 5 | 219 | 4 | 22223682 | |
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 21270429 | ||
| Pubmed | Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins. | 1.17e-08 | 13 | 219 | 5 | 15611625 | |
| Pubmed | 1.17e-08 | 13 | 219 | 5 | 12231349 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SETD1A KLF12 NEDD4 TNRC18 NFATC4 HTATSF1 BSN PRUNE2 ITSN1 AATK TP63 CHD5 ZFR EIF4G3 TP53BP2 TP73 | 1.75e-08 | 430 | 219 | 16 | 35044719 |
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 2.27e-08 | 6 | 219 | 4 | 18452650 | |
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 2.27e-08 | 6 | 219 | 4 | 31355046 | |
| Pubmed | 2.27e-08 | 6 | 219 | 4 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 2.27e-08 | 6 | 219 | 4 | 26077710 | |
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 2.27e-08 | 6 | 219 | 4 | 14611632 | |
| Pubmed | 2.27e-08 | 6 | 219 | 4 | 17219433 | ||
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 2.27e-08 | 6 | 219 | 4 | 16001084 | |
| Pubmed | 2.27e-08 | 6 | 219 | 4 | 32962040 | ||
| Pubmed | 2.27e-08 | 6 | 219 | 4 | 11390979 | ||
| Pubmed | 2.27e-08 | 6 | 219 | 4 | 27632217 | ||
| Pubmed | 2.27e-08 | 6 | 219 | 4 | 24086306 | ||
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 2.27e-08 | 6 | 219 | 4 | 19247806 | |
| Pubmed | 2.27e-08 | 6 | 219 | 4 | 20157580 | ||
| Pubmed | 2.27e-08 | 6 | 219 | 4 | 17526644 | ||
| Pubmed | 2.27e-08 | 6 | 219 | 4 | 1638086 | ||
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 2.27e-08 | 6 | 219 | 4 | 15066460 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 2.27e-08 | 6 | 219 | 4 | 23417416 | |
| Pubmed | 2.27e-08 | 6 | 219 | 4 | 32170089 | ||
| Pubmed | 2.27e-08 | 6 | 219 | 4 | 16278232 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 2.27e-08 | 6 | 219 | 4 | 1869307 | |
| Pubmed | 5.28e-08 | 7 | 219 | 4 | 22699423 | ||
| Pubmed | 5.28e-08 | 7 | 219 | 4 | 11604102 | ||
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 5.28e-08 | 7 | 219 | 4 | 16946704 | |
| Pubmed | 5.28e-08 | 7 | 219 | 4 | 11410654 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 5.28e-08 | 7 | 219 | 4 | 9588208 | |
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 5.28e-08 | 7 | 219 | 4 | 26826184 | |
| Pubmed | 5.28e-08 | 7 | 219 | 4 | 15081113 | ||
| Pubmed | 5.28e-08 | 7 | 219 | 4 | 10857750 | ||
| Pubmed | Characterization of a new family of cyclin-dependent kinase activators. | 5.50e-08 | 17 | 219 | 5 | 15574121 | |
| Pubmed | Epigenetic functions of smchd1 repress gene clusters on the inactive X chromosome and on autosomes. | 9.21e-08 | 59 | 219 | 7 | 23754746 | |
| Pubmed | 1.05e-07 | 8 | 219 | 4 | 29883445 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 1.05e-07 | 8 | 219 | 4 | 32339196 | |
| Pubmed | 1.05e-07 | 8 | 219 | 4 | 33749946 | ||
| Pubmed | 1.05e-07 | 8 | 219 | 4 | 22621333 | ||
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 1.05e-07 | 8 | 219 | 4 | 23204224 | |
| Pubmed | 1.05e-07 | 8 | 219 | 4 | 10823932 | ||
| Pubmed | 1.05e-07 | 8 | 219 | 4 | 11869379 | ||
| Pubmed | 1.05e-07 | 8 | 219 | 4 | 10951504 | ||
| Pubmed | 1.05e-07 | 8 | 219 | 4 | 32686646 | ||
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 1.88e-07 | 9 | 219 | 4 | 16310179 | |
| Interaction | PCDHB3 interactions | TEX264 HSPA5 PLXNA1 AHCTF1 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 PCDHB16 TADA1 EGFR ATP6AP2 | 2.15e-09 | 141 | 205 | 13 | int:PCDHB3 |
| Interaction | IL5RA interactions | MAN2B1 PXDN HSPA5 PLXNA1 MAN2B2 LAMC1 CELSR2 EGFR NPTXR LRP6 | 5.68e-07 | 124 | 205 | 10 | int:IL5RA |
| Interaction | PCDH12 interactions | 2.37e-06 | 22 | 205 | 5 | int:PCDH12 | |
| Interaction | LGALS1 interactions | ITGA6 NEO1 PTPRB SDK1 HSPA5 PLXNA1 SDK2 FN1 FAT3 MUC16 SIGLEC7 CELSR2 EGFR ATP6AP2 | 8.23e-06 | 332 | 205 | 14 | int:LGALS1 |
| Interaction | PCDHB13 interactions | 1.02e-05 | 5 | 205 | 3 | int:PCDHB13 | |
| Interaction | TOP3B interactions | SETD1A MAN2B1 VWA8 BCAS3 ARHGEF11 DYSF MYORG TMEM129 PHLDB1 TNRC18 PKD1 CPSF1 HERC2 HERC1 RBM47 LTBP4 HSPA5 HOXB13 PLXNA1 MED13 SEMA6C SH3RF1 WWP1 KAT6A ZBTB4 CEP192 AATK CELSR2 MTMR14 IL17RE ATP6AP2 CHD5 ZFR | 1.41e-05 | 1470 | 205 | 33 | int:TOP3B |
| Interaction | FBXO2 interactions | MAN2B1 CADM4 ITGA6 MYORG PXDN LTBP4 PLXNA1 NPTX2 SDK2 MAN2B2 FN1 LAMC1 EGFR NPTXR GAA | 2.16e-05 | 411 | 205 | 15 | int:FBXO2 |
| Interaction | WDR25 interactions | 2.68e-05 | 58 | 205 | 6 | int:WDR25 | |
| Interaction | SEMA6C interactions | 3.52e-05 | 7 | 205 | 3 | int:SEMA6C | |
| Interaction | PCDHB10 interactions | 3.52e-05 | 7 | 205 | 3 | int:PCDHB10 | |
| Interaction | UBASH3A interactions | 4.01e-05 | 124 | 205 | 8 | int:UBASH3A | |
| Interaction | MEX3A interactions | TMEM129 TNRC18 TOX4 PXDN RBM47 DNAH5 AHCTF1 ITSN1 KAT6A LAMC1 KHDC4 EYS TP53BP2 SLC25A45 | 4.13e-05 | 384 | 205 | 14 | int:MEX3A |
| Interaction | N6AMT1 interactions | 5.59e-05 | 8 | 205 | 3 | int:N6AMT1 | |
| Interaction | RYK interactions | PCDH17 NEO1 PCDH19 SDK1 SDK2 PCDHGA11 FAT3 CELSR2 AIFM1 PCDHGC3 | 6.54e-05 | 212 | 205 | 10 | int:RYK |
| Cytoband | 5q31 | PCDHGA11 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 PCDHB16 PCDHGC3 | 5.33e-09 | 115 | 221 | 9 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | SPDYE11 SPDYE13 SPDYE15 SPDYE21 SPDYE5 SPDYE14 SPDYE17 SPDYE10 SPDYE9 SPDYE12 SPDYE8 | 9.92e-08 | 271 | 221 | 11 | chr7q11 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | FSTL4 PCDHGA11 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 PCDHB16 PCDHGC3 | 2.13e-06 | 298 | 221 | 10 | chr5q31 |
| Cytoband | 7q11.23 | 1.11e-04 | 97 | 221 | 5 | 7q11.23 | |
| Cytoband | 5q21-q22 | 1.38e-04 | 4 | 221 | 2 | 5q21-q22 | |
| Cytoband | 7q22.1 | 2.27e-04 | 113 | 221 | 5 | 7q22.1 | |
| Cytoband | 3p26 | 6.34e-04 | 8 | 221 | 2 | 3p26 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 7.10e-04 | 219 | 221 | 6 | chr7q22 | |
| Cytoband | Yq11.223 | 1.09e-03 | 93 | 221 | 4 | Yq11.223 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 3.58e-10 | 12 | 158 | 6 | 756 | |
| GeneFamily | Clustered protocadherins | PCDHGA11 PCDHB15 PCDHB13 PCDHB10 PCDHB9 PCDHB3 PCDHAC2 PCDHB16 PCDHGC3 | 4.32e-09 | 64 | 158 | 9 | 20 |
| GeneFamily | Fibronectin type III domain containing | 8.27e-05 | 160 | 158 | 8 | 555 | |
| GeneFamily | Alkaline phosphatases | 4.50e-04 | 4 | 158 | 2 | 1072 | |
| GeneFamily | EYA transcriptional coactivator and phosphatases | 4.50e-04 | 4 | 158 | 2 | 1044 | |
| GeneFamily | Mannosidases alpha class 2 | 7.46e-04 | 5 | 158 | 2 | 1194 | |
| GeneFamily | Long pentraxins | 7.46e-04 | 5 | 158 | 2 | 1142 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.08e-03 | 181 | 158 | 7 | 694 | |
| GeneFamily | Immunoglobulin like domain containing | 1.56e-03 | 193 | 158 | 7 | 594 | |
| GeneFamily | PDZ domain containing | 2.20e-03 | 152 | 158 | 6 | 1220 | |
| GeneFamily | RNA binding motif containing | 2.72e-03 | 213 | 158 | 7 | 725 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.93e-03 | 161 | 158 | 6 | 593 | |
| GeneFamily | Non-clustered protocadherins | 4.73e-03 | 12 | 158 | 2 | 21 | |
| GeneFamily | CD molecules|Type II classical cadherins | 5.56e-03 | 13 | 158 | 2 | 1186 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | CPNE8 ITGA6 SVEP1 RUSC2 PHLDB1 PCDH19 PKD1 LTBP4 NPTX2 SDK2 LAMC1 EGFR TP63 OSR1 MYOCD TNS1 PCDHGC3 | 4.17e-07 | 479 | 212 | 17 | M2573 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | CPNE8 ITGA6 SVEP1 RUSC2 PHLDB1 PCDH19 PKD1 LTBP4 NPTX2 SDK2 LAMC1 EGFR TP63 OSR1 MYOCD TNS1 PCDHGC3 | 4.68e-07 | 483 | 212 | 17 | MM1082 |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 1.96e-06 | 12 | 212 | 4 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 1.96e-06 | 12 | 212 | 4 | MM781 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | CDC42EP4 PSEN2 CADM4 ITGA6 DAZ1 ARHGEF11 PHLDB1 DAZ3 DAZ2 LTBP4 PLXNA1 SDK2 FN1 DAZ4 ITSN1 SIGLEC7 CHD5 POLR2J2 TNS1 PCDHGC3 TP73 | 1.69e-05 | 909 | 212 | 21 | M41018 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HIVEP1 ITGA6 NEDD4 CEP350 MED13 RANBP2 WWP1 AHCTF1 ITSN1 KAT6A APC ARFGEF1 LAMC1 BHLHE40 EGFR FARS2 MPHOSPH9 EIF4G3 PARD3 TP53BP2 | 2.31e-05 | 856 | 212 | 20 | M4500 |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 3.27e-05 | 23 | 212 | 4 | MM1293 | |
| Coexpression | SABATES_COLORECTAL_ADENOMA_DN | 3.49e-05 | 299 | 212 | 11 | M14791 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP | 3.88e-05 | 200 | 212 | 9 | M7500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | KLF12 PAG1 EYA1 PCDH17 CEP350 NFATC4 HOXB13 MED13 FAT3 APC SLCO5A1 EGFR IL17RE TP63 OSR1 MYOCD CDH10 | 5.93e-07 | 407 | 208 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | KLF12 PAG1 CPNE8 BCAS3 EYA1 PCDH17 CEP350 GLI3 FLRT3 HERC2 HOXB13 MED13 ANK2 SFSWAP FAT3 PCDHB13 APC LAMC1 SLCO5A1 IL17RE TP63 OSR1 MYOCD CDH10 | 1.73e-06 | 818 | 208 | 24 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | KLF12 PAG1 VWA8 BDH1 RUSC2 CEP350 PHF2 PCDH19 ANKRD12 LTBP4 SEMA6C CACNB1 ANK2 FAT3 ADCK2 SLCO5A1 TADA1 AATK RTL1 NPTXR CNTNAP2 | 2.19e-06 | 658 | 208 | 21 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | SETD1A KLF12 ISLR PDE10A SVEP1 TNRC18 HOXC6 HTATSF1 ANKRD12 HERC1 LTBP4 SEMA6C SDK2 SH3RF1 SFSWAP FAT3 ZBTB4 PCDHB13 PCDHB9 LRP6 ZFR MYOCD TNS1 | 3.29e-06 | 790 | 208 | 23 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | KLF12 EYA1 PCDH17 CEP350 FLRT3 MED13 NOVA1 FAT3 PCDHB13 PCDHB3 APC EBF1 SLCO5A1 TP63 MYOCD CDH10 | 5.19e-06 | 427 | 208 | 16 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2 | KLF12 PAG1 VWA8 SHC3 RUSC2 CEP350 PHF2 PCDH19 SEMA6C CACNB1 ANK2 FAT3 ADCK2 CFAP210 TADA1 AATK RTL1 NPTXR FAM222A CNTNAP2 | 8.15e-06 | 659 | 208 | 20 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2 |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_500 | PAG1 CDC42EP4 PDE10A PCDH17 MYORG TNRC18 FLRT3 SH3RF1 FN1 BHLHE40 PKHD1L1 CSF3R ZNF792 FAM222A CNTNAP2 MYOCD CDH10 | 8.26e-06 | 495 | 208 | 17 | PCBC_ratio_DE_vs_SC_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | KLF12 PAG1 VWA8 BDH1 RUSC2 CEP350 PHF2 PCDH19 LTBP4 SEMA6C CACNB1 FAT3 ADCK2 SLCO5A1 TADA1 AATK RTL1 NPTXR CNTNAP2 | 1.06e-05 | 614 | 208 | 19 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | KLF12 VWA8 BDH1 RUSC2 CEP350 PHF2 GLI3 PCDH19 ANKRD12 LTBP4 NOVA1 ANK2 FAT3 ADCK2 SLCO5A1 TADA1 AATK CELSR2 RTL1 NPTXR CNTNAP2 | 1.13e-05 | 732 | 208 | 21 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | KLF12 PAG1 BDH1 RUSC2 CEP350 PHF2 PCDH19 LTBP4 SEMA6C CACNB1 FAT3 ADCK2 SLCO5A1 TADA1 AATK CELSR2 RTL1 NPTXR FAM222A CNTNAP2 | 1.37e-05 | 683 | 208 | 20 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | KLF12 PAG1 VWA8 BDH1 RUSC2 CEP350 PHF2 PCDH19 LTBP4 SEMA6C CACNB1 ANK2 FAT3 ADCK2 SLCO5A1 TADA1 AATK RTL1 NPTXR CNTNAP2 | 1.52e-05 | 688 | 208 | 20 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | KLF12 PAG1 VWA8 BDH1 RUSC2 CEP350 PHF2 PCDH19 LTBP4 SEMA6C CACNB1 ANK2 FAT3 ADCK2 SLCO5A1 TADA1 AATK CELSR2 RTL1 NPTXR CNTNAP2 | 1.52e-05 | 747 | 208 | 21 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | PAG1 EYA1 CHRNA1 FLRT3 PCDHB15 PCDHB13 PCDHB10 PCDHB3 ZNF365 PCDHB16 SLCO5A1 | 1.70e-05 | 229 | 208 | 11 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k1 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | TRAF3IP2 CPNE8 ISLR SVEP1 HOXC6 GLI3 FLRT3 MUC16 BHLHE40 NKD1 MCU OSR1 CDH10 | 2.19e-05 | 327 | 208 | 13 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5 | KLF12 PAG1 VWA8 BDH1 RUSC2 CEP350 PHF2 PCDH19 LTBP4 SEMA6C CACNB1 ANK2 FAT3 ADCK2 SLCO5A1 TADA1 AATK RTL1 NPTXR CNTNAP2 | 3.02e-05 | 722 | 208 | 20 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | SETD1A KLF12 ISLR PDE10A SVEP1 HOXA7 TNRC18 HOXC6 PCDH19 ANKRD12 HERC1 LTBP4 SEMA6C SH3RF1 SFSWAP FAT3 PCDHB13 PCDHB9 NKD1 LRP6 TNS1 | 4.24e-05 | 801 | 208 | 21 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | KLF12 PAG1 EYA1 ERGIC2 PCDH17 CEP350 PCDH19 HERC2 MED13 NOVA1 NPTX2 FAT3 PCDHB13 PCDHB3 APC LAMC1 SLCO5A1 EGFR TP63 MYOCD CDH10 | 4.63e-05 | 806 | 208 | 21 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | KLF12 PAG1 VWA8 EYA1 PCDH17 CEP350 NFATC4 GLI3 HOXB13 MED13 FAT3 PCDHB3 APC LAMC1 SLCO5A1 EGFR IL17RE TP63 OSR1 MYOCD CDH10 | 4.63e-05 | 806 | 208 | 21 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | SKIDA1 ITGA6 SHC3 PCDH17 RUSC2 TOX4 LTBP4 ZBTB4 AATK EGFR RTL1 NPTXR | 5.20e-05 | 306 | 208 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | KLF12 PAG1 EYA1 PCDH17 CEP350 HERC2 MED13 NPTX2 FAT3 APC EGFR TP63 MYOCD CDH10 | 5.33e-05 | 408 | 208 | 14 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | TRAF3IP2 CPNE8 ISLR SVEP1 GLI3 FLRT3 MUC16 BHLHE40 NKD1 EGFR OSR1 CDH10 | 6.07e-05 | 311 | 208 | 12 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | KLF12 CPNE8 ISLR EYA1 SVEP1 HOXC6 GLI3 LTBP4 FN1 FAT3 MUC16 BHLHE40 EGFR | 6.08e-05 | 361 | 208 | 13 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#1 | 7.44e-05 | 104 | 208 | 7 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | PAG1 EYA1 CHRNA1 NEO1 FLRT3 MED13 FAT3 PCDHB15 PCDHB13 PCDHB10 PCDHB3 EBF1 CDH19 ZNF365 PCDHB16 SLCO5A1 EGFR FARS2 TP63 ZFR CDH10 | 7.79e-05 | 836 | 208 | 21 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | KLF12 PAG1 VWA8 BDH1 RUSC2 CEP350 PHF2 PCDH19 LTBP4 SEMA6C ANK2 FAT3 ADCK2 SLCO5A1 TADA1 AATK RTL1 NPTXR CNTNAP2 | 9.31e-05 | 721 | 208 | 19 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | KLF12 HIVEP1 ZGRF1 ISLR NEO1 GLI3 PCDH19 ANKRD12 FLRT3 NOVA1 ANK2 PCDHB3 EBF1 PCDHB16 NKD1 EGFR FARS2 MYOCD CDH10 GAA | 1.06e-04 | 791 | 208 | 20 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | KLF12 PAG1 BCAS3 PCDH17 CEP350 GLI3 HERC2 MED13 SFSWAP FAT3 APC LAMC1 MYOCD | 1.16e-04 | 385 | 208 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | TRAF3IP2 CPNE8 CADM4 ITGA6 ISLR NEO1 TNRC18 HOXC6 GLI3 FLRT3 ISYNA1 FN1 FAT3 MUC16 BHLHE40 NKD1 EGFR MCU OSR1 CDH10 | 1.18e-04 | 797 | 208 | 20 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | SETD1A KLF12 ISLR TNRC18 HOXC6 HTATSF1 ANKRD12 HERC1 LTBP4 SEMA6C SH3RF1 SFSWAP FAT3 PCDHB13 PCDHB9 HTRA3 BHLHE40 LRP6 MYOCD TNS1 | 1.22e-04 | 799 | 208 | 20 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.24e-04 | 151 | 208 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | PAG1 EYA1 ANK2 PCDHB13 PCDHB10 PCDHB3 ZNF365 PCDHB16 SLCO5A1 | 1.25e-04 | 193 | 208 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 1.30e-04 | 194 | 208 | 9 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | KLF12 HIVEP1 ISLR ANKRD12 NOVA1 ANK2 PCDHB3 EBF1 PCDHB16 EGFR CDH10 | 1.35e-04 | 288 | 208 | 11 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | KLF12 PAG1 VWA8 BDH1 RUSC2 CEP350 PHF2 PCDH19 LTBP4 CACNB1 ANK2 FAT3 ADCK2 SLCO5A1 TADA1 AATK RTL1 NPTXR CNTNAP2 | 1.37e-04 | 743 | 208 | 19 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | CDC42EP4 EVI2A GFRA4 ARHGEF11 SVEP1 PCDH17 MYORG NFATC4 GLI3 PCDH19 PKD1 ANKRD12 FLRT3 SDK1 SEMA6C CACNB1 SDK2 FN1 FAT3 HTRA3 ZNF365 PCDHB16 NKD1 TTI1 ZFR GAA | 1.38e-04 | 1208 | 208 | 26 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.46e-04 | 197 | 208 | 9 | gudmap_developingGonad_e16.5_epididymis_1000_k5 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | CADM4 SKIDA1 ITGA6 RUSC2 PHLDB1 NEO1 NFATC4 GLI3 SPON1 NECTIN1 HERC1 ISYNA1 SDK2 PCDHGA11 PCDHB15 KAT6A ZBTB4 PCDHB10 PCDHB9 TACC2 KHDC4 CELSR2 PCDHGC3 GAA | 1.47e-04 | 1075 | 208 | 24 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | KLF12 PAG1 VWA8 BDH1 RUSC2 CEP350 PHF2 PCDH19 LTBP4 CACNB1 ANK2 FAT3 ADCK2 SLCO5A1 TADA1 AATK RTL1 NPTXR CNTNAP2 | 1.47e-04 | 747 | 208 | 19 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | KLF12 PAG1 EYA1 ERGIC2 PCDH17 CEP350 FLRT3 HERC2 MED13 NOVA1 ANK2 FAT3 PCDHB13 PCDHB3 APC EBF1 SLCO5A1 TP63 MYOCD CDH10 | 1.66e-04 | 818 | 208 | 20 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#5 | PDE10A PCDH17 MYORG FLRT3 SH3RF1 CSF3R ZNF792 FAM222A CNTNAP2 MYOCD CDH10 | 1.76e-04 | 297 | 208 | 11 | ratio_DE_vs_SC_500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | PAG1 EYA1 CHRNA1 PCDH17 SPON1 FLRT3 ANK2 PCDHB15 PCDHB13 PCDHB10 PCDHB3 EBF1 CDH19 ZNF365 PCDHB16 SLCO5A1 EGFR FARS2 TP63 CDH10 | 1.92e-04 | 827 | 208 | 20 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | SETD1A KLF12 TNRC18 HOXC6 HERC1 LTBP4 SH3RF1 SFSWAP FAT3 PCDHB13 PCDHB9 MYOCD TNS1 | 1.95e-04 | 406 | 208 | 13 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | CPNE8 ISLR SVEP1 CEP350 HOXC6 GLI3 FLRT3 FAT3 MUC16 NKD1 OSR1 CDH10 | 2.05e-04 | 354 | 208 | 12 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 2.12e-04 | 207 | 208 | 9 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | KLF12 ITGA6 EYA1 PCDH17 CEP350 NFATC4 GLI3 SPON1 FLRT3 MED13 PCDHB15 PCDHB13 APC ZNF365 SLCO5A1 NKD1 EGFR FARS2 TP63 | 2.13e-04 | 769 | 208 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500 | 2.29e-04 | 165 | 208 | 8 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | SETD1A KLF12 PDE10A TNRC18 HOXC6 PCDH19 HERC1 SH3RF1 SFSWAP FAT3 PCDHB13 PCDHB9 TNS1 | 2.31e-04 | 413 | 208 | 13 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | BCAS3 CADM4 SKIDA1 RUSC2 PHF2 NEO1 TNRC18 PXDN NFATC4 GLI3 SPON1 PKD1 FLRT3 LTBP4 PLXNA1 SEMA6C ISYNA1 SDK2 ANK2 PCDHGA11 PCDHB15 KAT6A ZBTB4 PCDHB10 PCDHB9 KHDC4 CELSR2 PCDHGC3 GAA | 2.35e-04 | 1466 | 208 | 29 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | TRAF3IP2 KLF12 CPNE8 ZGRF1 ISLR EYA1 SVEP1 HOXC6 GLI3 LTBP4 FN1 FAT3 MUC16 CEP192 BHLHE40 NKD1 EGFR MYOCD TNS1 | 2.43e-04 | 777 | 208 | 19 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.99e-04 | 265 | 208 | 10 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | KLF12 PAG1 EYA1 ERGIC2 PCDH17 CEP350 HERC2 MED13 FAT3 APC LAMC1 MYOCD | 2.99e-04 | 369 | 208 | 12 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 2.99e-04 | 130 | 208 | 7 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_500 | 3.09e-04 | 93 | 208 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k4_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | TRAF3IP2 CPNE8 HIVEP1 ISLR SVEP1 NEO1 TNRC18 HOXC6 GLI3 FLRT3 ISYNA1 SDK2 FN1 MUC16 CFAP210 BHLHE40 NKD1 MCU OSR1 CDH10 | 3.10e-04 | 858 | 208 | 20 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | TRAF3IP2 KLF12 CPNE8 ISLR EYA1 SVEP1 HOXC6 GLI3 NECTIN1 LTBP4 ISYNA1 FN1 FAT3 MUC16 CEP192 BHLHE40 EGFR MYOCD CDH10 | 3.13e-04 | 793 | 208 | 19 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | KLF12 PAG1 VWA8 BDH1 RUSC2 CEP350 PHF2 PCDH19 LTBP4 ANK2 FAT3 ADCK2 SLCO5A1 TADA1 AATK RTL1 NPTXR CNTNAP2 | 3.21e-04 | 730 | 208 | 18 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | PAG1 EYA1 CHRNA1 NEO1 FAT2 FLRT3 PCDHB15 PCDHB10 PCDHB3 ZNF365 SLCO5A1 EGFR TP63 | 3.25e-04 | 428 | 208 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | TRAF3IP2 KLF12 CPNE8 ISLR EYA1 GLI3 LTBP4 FN1 FAT3 MUC16 BHLHE40 EGFR | 3.29e-04 | 373 | 208 | 12 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | TRAF3IP2 CPNE8 ITGA6 ISLR NEO1 HOXC6 GLI3 LTBP4 ISYNA1 FN1 FAT3 MUC16 CFAP210 BHLHE40 NKD1 EGFR MCU OSR1 MYOCD | 3.33e-04 | 797 | 208 | 19 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#1 | PDE10A PCDH17 MYORG FLRT3 SH3RF1 FN1 PKHD1L1 ZNF792 FAM222A CNTNAP2 MYOCD CDH10 | 3.37e-04 | 374 | 208 | 12 | ratio_DE_vs_SC_500_K1 |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#3 | 4.73e-04 | 66 | 208 | 5 | ratio_DE_vs_SC_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | KLF12 PAG1 BDH1 SHC3 RUSC2 CEP350 PCDH19 LTBP4 NOVA1 CACNB1 ANK2 FAT3 ADCK2 CFAP210 SLCO5A1 TADA1 AATK RTL1 NPTXR CNTNAP2 | 5.14e-04 | 893 | 208 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | CPNE8 ISLR SVEP1 HOXC6 GLI3 FLRT3 FAT3 MUC16 NKD1 OSR1 CDH10 | 5.15e-04 | 337 | 208 | 11 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | BCAS3 CADM4 SKIDA1 CABYR PHLDB1 FIG4 NFATC4 GLI3 SPON1 NECTIN1 HERC1 ISYNA1 SDK2 PCDHGA11 PCDHB15 KAT6A PCDHB10 PCDHB9 TACC2 CELSR2 PCDHGC3 | 5.56e-04 | 967 | 208 | 21 | PCBC_ratio_ECTO_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.24e-04 | 240 | 208 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_500 | 6.52e-04 | 148 | 208 | 7 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 6.79e-04 | 149 | 208 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | ISLR SVEP1 NEO1 PXDN SPON1 LTBP4 FN1 LAMC1 HTRA3 EBF1 EGFR OSR1 GAA | 7.21e-04 | 466 | 208 | 13 | GSM777050_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_100 | 8.00e-04 | 19 | 208 | 3 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k2_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | KLF12 PCDH17 CEP350 FLRT3 HOXB13 MED13 APC SLCO5A1 IL17RE TP63 OSR1 CDH10 | 8.62e-04 | 416 | 208 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.01e-03 | 310 | 208 | 10 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_500 | EYA1 CHRNA1 ANK2 PCDHB15 PCDHB13 PCDHB10 PCDHB3 EBF1 ZNF365 SLCO5A1 FARS2 CDH10 | 1.02e-03 | 424 | 208 | 12 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.06e-03 | 312 | 208 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 1.08e-03 | 21 | 208 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k4_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_200 | 1.23e-03 | 165 | 208 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500 | EYA1 SHC3 PCDH17 NECTIN1 RBM47 SDK1 CFAP210 SLCO5A1 CELSR2 EGFR FAM222A TP63 CTSE | 1.25e-03 | 495 | 208 | 13 | Facebase_RNAseq_e10.5_Olfactory Pit_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_200 | 1.28e-03 | 166 | 208 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | ISLR SVEP1 NEO1 PXDN LTBP4 NOVA1 FN1 LAMC1 HTRA3 EBF1 EGFR TNS1 | 1.31e-03 | 437 | 208 | 12 | GSM777046_500 |
| ToppCell | IPF-Stromal-Fibroblast|IPF / Disease state, Lineage and Cell class | ISLR SVEP1 PHLDB1 SPON1 LTBP4 NOVA1 ANK2 LAMC1 HTRA3 EBF1 EGFR OSR1 | 2.55e-10 | 196 | 217 | 12 | f7ae604ba32b322d86d68b2b54892e7c6ab06c49 |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CPNE8 FSTL4 EYA1 FAT2 GLI3 FLRT3 SDK1 ISYNA1 EGFR TP63 TNS1 TP73 | 3.04e-10 | 199 | 217 | 12 | 94a7867e800df352731796de8c24cba133c29622 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ISLR SVEP1 NFATC4 SPON1 LTBP4 NOVA1 ANK2 LAMC1 HTRA3 EBF1 OSR1 | 2.46e-09 | 189 | 217 | 11 | d531399749409d614adca13d181830c6e3287508 |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | SVEP1 PHLDB1 PXDN LTBP4 NOVA1 FN1 LAMC1 HTRA3 EBF1 CDH19 EGFR | 3.24e-09 | 194 | 217 | 11 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 |
| ToppCell | IPF-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | ISLR SVEP1 PHLDB1 SPON1 LTBP4 NOVA1 ANK2 HTRA3 EBF1 EGFR OSR1 | 3.42e-09 | 195 | 217 | 11 | 9c32756edb54f0c211185d9a98073fe01fd1526a |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ISLR SVEP1 SPON1 LTBP4 NOVA1 ANK2 LAMC1 HTRA3 EBF1 OSR1 PCDHGC3 | 3.42e-09 | 195 | 217 | 11 | f54bc4454270ff06e85596f98199372b50d0179f |
| ToppCell | Control-Stromal|Control / Disease state, Lineage and Cell class | 4.01e-09 | 198 | 217 | 11 | ae726b6b7f0a4107899be4d32ac256ffa0bd8d59 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.23e-09 | 199 | 217 | 11 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.46e-09 | 200 | 217 | 11 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Basal_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | EYA1 PDE10A FAT2 DQX1 ISYNA1 PCDHGA11 CAPNS2 BHLHE40 TP63 CNTNAP2 | 5.94e-09 | 158 | 217 | 10 | 51e3ed1b91b010404d66e3e7efdbffc0c815e25b |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.12e-08 | 188 | 217 | 10 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.81e-08 | 192 | 217 | 10 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 4.20e-08 | 194 | 217 | 10 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 4.41e-08 | 195 | 217 | 10 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.41e-08 | 195 | 217 | 10 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 5.10e-08 | 198 | 217 | 10 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.34e-08 | 199 | 217 | 10 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.34e-08 | 199 | 217 | 10 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-08 | 199 | 217 | 10 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.60e-08 | 200 | 217 | 10 | bfa73bc5f8a6c7de8353ca049a921ef19f7f4437 | |
| ToppCell | Biopsy_IPF-Epithelial-Basal|Biopsy_IPF / Sample group, Lineage and Cell type | 5.60e-08 | 200 | 217 | 10 | 5cea84581201cee7ba8141b96e65864f4fd67113 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.60e-08 | 200 | 217 | 10 | b04831708fa20471a127b87e8db3728b6e729ce8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.13e-07 | 163 | 217 | 9 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-07 | 177 | 217 | 9 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 3.30e-07 | 185 | 217 | 9 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.30e-07 | 185 | 217 | 9 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.61e-07 | 187 | 217 | 9 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | PAG1 ANKRD12 HERC1 MED13 RANBP2 POLR2J3 AHCTF1 ARFGEF1 TP53BP2 | 3.78e-07 | 188 | 217 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.95e-07 | 189 | 217 | 9 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.31e-07 | 191 | 217 | 9 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.31e-07 | 191 | 217 | 9 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.51e-07 | 192 | 217 | 9 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.51e-07 | 192 | 217 | 9 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.51e-07 | 192 | 217 | 9 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.51e-07 | 192 | 217 | 9 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 4.51e-07 | 192 | 217 | 9 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-07 | 193 | 217 | 9 | 59b8186d0221fba06a16157e9d148399ed801f38 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-07 | 193 | 217 | 9 | dc92680b4bb9fc26430c92e03adb839c8c3b3b98 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.71e-07 | 193 | 217 | 9 | 7c34abdcb8839b9fb25457a79af6c5e7b9714b21 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.71e-07 | 193 | 217 | 9 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.71e-07 | 193 | 217 | 9 | 3d85c28f6ebdcb15e875ad01d52d6c138fbf8525 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 4.71e-07 | 193 | 217 | 9 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-07 | 193 | 217 | 9 | 03678162648bd5b1d65a5450b60c8863edbf95c7 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 4.71e-07 | 193 | 217 | 9 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 4.92e-07 | 194 | 217 | 9 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.92e-07 | 194 | 217 | 9 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 4.92e-07 | 194 | 217 | 9 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 4.92e-07 | 194 | 217 | 9 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.92e-07 | 194 | 217 | 9 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-07 | 195 | 217 | 9 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.13e-07 | 195 | 217 | 9 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.13e-07 | 195 | 217 | 9 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-07 | 195 | 217 | 9 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-07 | 195 | 217 | 9 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.36e-07 | 196 | 217 | 9 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.36e-07 | 196 | 217 | 9 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | Control-Stromal-Fibroblast|Control / Disease state, Lineage and Cell class | 5.36e-07 | 196 | 217 | 9 | 7ca94477498a84cafcdd9933ee92a6cbde76c70e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.36e-07 | 196 | 217 | 9 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.59e-07 | 197 | 217 | 9 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | facs-Heart-LA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-07 | 197 | 217 | 9 | 2a91738cb6d7588869dd00deeea0cbbc2d6aa34d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.59e-07 | 197 | 217 | 9 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | COPD-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 5.83e-07 | 198 | 217 | 9 | 2f13c0b3372af53d1bd85f9546f315c878580a71 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.83e-07 | 198 | 217 | 9 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.83e-07 | 198 | 217 | 9 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.83e-07 | 198 | 217 | 9 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.83e-07 | 198 | 217 | 9 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.08e-07 | 199 | 217 | 9 | 84545ced0c792bc77980a50d65e484eab648d47e | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.08e-07 | 199 | 217 | 9 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.08e-07 | 199 | 217 | 9 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.08e-07 | 199 | 217 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.08e-07 | 199 | 217 | 9 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 6.08e-07 | 199 | 217 | 9 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.08e-07 | 199 | 217 | 9 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.08e-07 | 199 | 217 | 9 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.08e-07 | 199 | 217 | 9 | 0019cfaa586a450c2e4952d1184a540561c8d0ba | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.08e-07 | 199 | 217 | 9 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.08e-07 | 199 | 217 | 9 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.08e-07 | 199 | 217 | 9 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | Biopsy_IPF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 6.34e-07 | 200 | 217 | 9 | 2c5626ea8fb4b702d4560117e53edf6cfcf1971e | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.34e-07 | 200 | 217 | 9 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.34e-07 | 200 | 217 | 9 | 17ffdbc13332bd3ed1d54abcd7af20267dd4b234 | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_2|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.34e-07 | 200 | 217 | 9 | 1fa29a9f42987549a75dffeb177099458f7cca88 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.34e-07 | 200 | 217 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.34e-07 | 200 | 217 | 9 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.34e-07 | 200 | 217 | 9 | 2e4ab7fbd94d3d865ef6188d3b4916d2bf1b8d89 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.34e-07 | 200 | 217 | 9 | 6316c288022719b9e6c4332c5cb9041e1188d0e8 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.34e-07 | 200 | 217 | 9 | 1e75d1302c22e1b1666c19c0c9259d5cc8be16d5 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.34e-07 | 200 | 217 | 9 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.34e-07 | 200 | 217 | 9 | 0a86656d48e4238d0e4d592d477d29f7ba7c2ec0 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.34e-07 | 200 | 217 | 9 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.34e-07 | 200 | 217 | 9 | 3fa7d9ea67f9cc55478d085da53babd03dbe9bb1 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.34e-07 | 200 | 217 | 9 | 74ad0ae592252060ee294d7483327d765a6ba1dd | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.34e-07 | 200 | 217 | 9 | fd92d8250c6ad1e8bb46b303ac37f8dcf80387d8 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.34e-07 | 200 | 217 | 9 | f6cf98aad53aa8b3fa02cf874d6f7cd75530a213 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.34e-07 | 200 | 217 | 9 | 5c6520dc4c4693827f6680651785680b5883afb8 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.34e-07 | 200 | 217 | 9 | 7ba292c30d915e66ebc8026fa76492cedf64700e | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 6.34e-07 | 200 | 217 | 9 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.77e-06 | 168 | 217 | 8 | 6521bead9789d626b86cbd08692c621c5a5aef33 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-06 | 169 | 217 | 8 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.85e-06 | 169 | 217 | 8 | c3ee781735a9288ce1822b230d39bb91c1415589 | |
| Drug | boron trichloride | 1.02e-07 | 6 | 209 | 4 | CID000025135 | |
| Drug | desmethylazelastine | 2.50e-07 | 16 | 209 | 5 | CID000162558 | |
| Drug | Scopolamine hydrochloride [55-16-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A | ARHGEF11 TOX4 PTPRB CARD14 ALPI CACNB1 HTR1B APC BHLHE40 CHD5 LRP6 TNS1 | 2.99e-07 | 197 | 209 | 12 | 4803_UP |
| Drug | Naloxone hydrochloride [357-08-4]; Up 200; 11uM; PC3; HG-U133A | TRAF3IP2 BDH1 PCDH17 PHF2 HOXB13 CACNB1 ANK2 SFSWAP ARFGEF1 FARS2 ATG12 GAA | 3.16e-07 | 198 | 209 | 12 | 1924_UP |
| Drug | 6-bromocyclohex-4-ene-1,2,3-triol | 5.02e-07 | 33 | 209 | 6 | CID000122062 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | KLF12 ITGA6 GLI3 XYLB HOXB13 PLXNA1 APC ARFGEF1 BHLHE40 ZNF365 PARD3 | 7.73e-07 | 177 | 209 | 11 | 4652_DN |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | PDE10A RUSC2 PHLDB1 BSN LTBP4 PRUNE2 HTR1B FN1 KAT6A FUT6 TNS1 | 2.21e-06 | 197 | 209 | 11 | 6043_UP |
| Drug | Gleevec; Down 200; 10uM; MCF7; HG-U133A | FSTL4 PDE10A F7 CACNB1 SDK2 ANK2 ITSN1 SLURP1 EGFR TP63 LRP6 | 2.44e-06 | 199 | 209 | 11 | 366_DN |
| Drug | thioridazine hydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | KLF12 ITGA6 PDE10A XYLB HOXB13 ISYNA1 FN1 PGGHG ITSN1 KAT6A CNTNAP2 | 2.56e-06 | 200 | 209 | 11 | 5921_DN |
| Drug | d-gluconhydroximo-1,5-lactam | 8.69e-06 | 31 | 209 | 5 | CID000003479 | |
| Drug | Articaine hydrochloride [23964-57-0]; Up 200; 12.4uM; HL60; HT_HG-U133A | KLF12 OR7E24 BCAS3 ARHGEF11 BMPR2 PTPRN2 PRUNE2 ADCK2 EGFR CTSE | 1.49e-05 | 197 | 209 | 10 | 3138_UP |
| Drug | 5-amino-5-deoxy-D-mannopyranose | 1.49e-05 | 6 | 209 | 3 | CID000124624 | |
| Drug | Bromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.55e-05 | 198 | 209 | 10 | 6037_UP | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 1uM; MCF7; HT_HG-U133A | ARHGEF11 PCDH17 LTBP4 CARD14 PGGHG AATK SIGLEC7 TP63 CTSE TNS1 | 1.69e-05 | 200 | 209 | 10 | 3968_UP |
| Drug | deoxyfuconojirimycin | 2.13e-05 | 37 | 209 | 5 | CID000122618 | |
| Drug | AC1L1I1D | 2.13e-05 | 37 | 209 | 5 | CID000004381 | |
| Drug | dazmegrel | 2.40e-05 | 19 | 209 | 4 | CID000053555 | |
| Drug | YM 026 | 2.40e-05 | 19 | 209 | 4 | CID000004443 | |
| Drug | cyclophellitol | 2.40e-05 | 19 | 209 | 4 | CID000164227 | |
| Drug | Plantagoside | 2.60e-05 | 7 | 209 | 3 | CID000174157 | |
| Drug | AZFd | 5.33e-05 | 23 | 209 | 4 | CID000196489 | |
| Drug | dansylaziridine | 5.33e-05 | 23 | 209 | 4 | CID000104008 | |
| Drug | indolizidine | 7.50e-05 | 25 | 209 | 4 | CID000026136 | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; HL60; HT_HG-U133A | 8.33e-05 | 195 | 209 | 9 | 2149_UP | |
| Drug | Bambuterol hydrochloride [81732-46-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 8.33e-05 | 195 | 209 | 9 | 3199_UP | |
| Drug | Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 8.67e-05 | 196 | 209 | 9 | 4169_UP | |
| Drug | Flurandrenolide [1524-88-5]; Up 200; 9.2uM; PC3; HT_HG-U133A | 8.67e-05 | 196 | 209 | 9 | 7378_UP | |
| Drug | Rolitetracycline [751-97-3]; Up 200; 7.6uM; HL60; HT_HG-U133A | 8.67e-05 | 196 | 209 | 9 | 3031_UP | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HG-U133A | 8.67e-05 | 196 | 209 | 9 | 490_UP | |
| Drug | ( )-Calystegine A3 | 8.73e-05 | 10 | 209 | 3 | CID000183073 | |
| Drug | Dfj | 8.73e-05 | 10 | 209 | 3 | CID009549198 | |
| Drug | LY294002; Up 200; 10uM; ssMCF7; HG-U133A | 9.01e-05 | 197 | 209 | 9 | 401_UP | |
| Drug | Propofol [2078-54-8]; Up 200; 22.4uM; HL60; HT_HG-U133A | 9.01e-05 | 197 | 209 | 9 | 3048_UP | |
| Drug | Dubinidine [22964-77-8]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 209 | 9 | 3554_UP | |
| Drug | Cyproterone acetate [427-51-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 6806_UP | |
| Drug | Sisomicin sulfate [53179-09-2]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 4132_UP | |
| Drug | Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; HL60; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 3059_UP | |
| Drug | Trimethadione [127-48-0]; Up 200; 28uM; HL60; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 2486_UP | |
| Drug | Crotamiton [483-63-6]; Up 200; 19.6uM; HL60; HT_HG-U133A | 9.73e-05 | 199 | 209 | 9 | 3050_UP | |
| Drug | Prednisone [53-03-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 9.73e-05 | 199 | 209 | 9 | 4400_UP | |
| Drug | Lincomycin hydrochloride [859-18-7]; Up 200; 9uM; MCF7; HT_HG-U133A | 9.73e-05 | 199 | 209 | 9 | 5992_UP | |
| Drug | Ozagrel hydrochloride [78712-43-3]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 1.01e-04 | 200 | 209 | 9 | 3503_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HG-U133A | 1.01e-04 | 200 | 209 | 9 | 409_DN | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 1uM; PC3; HT_HG-U133A | 1.01e-04 | 200 | 209 | 9 | 3776_UP | |
| Disease | Male sterility due to Y-chromosome deletions | 1.35e-07 | 8 | 198 | 4 | C2931163 | |
| Disease | Partial chromosome Y deletion | 1.35e-07 | 8 | 198 | 4 | C1507149 | |
| Disease | Colorectal Carcinoma | ISLR CABYR PTPRN2 GLI3 ABCC2 PZP CACNB1 FN1 ANK2 APC ARFGEF1 LAMC1 SIGLEC7 EGFR TP63 CHD5 | 2.32e-05 | 702 | 198 | 16 | C0009402 |
| Disease | adenoma (is_implicated_in) | 4.48e-05 | 2 | 198 | 2 | DOID:657 (is_implicated_in) | |
| Disease | neogenin measurement | 1.34e-04 | 3 | 198 | 2 | EFO_0801823 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 1.56e-04 | 16 | 198 | 3 | C1839071 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 1.56e-04 | 16 | 198 | 3 | cv:C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 1.56e-04 | 16 | 198 | 3 | 415000 | |
| Disease | breast carcinoma | PAG1 BCAS3 SKIDA1 ATP6AP1L PTPRN2 LYPD5 LAMC1 TACC2 CEP192 EBF1 SPDYE12 KHDC4 ZNF365 NKD1 EGFR NPTXR PADI6 TNS1 | 1.89e-04 | 1019 | 198 | 18 | EFO_0000305 |
| Disease | Glioblastoma | 1.95e-04 | 79 | 198 | 5 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 2.60e-04 | 84 | 198 | 5 | C0334588 | |
| Disease | Cleft lip and alveolus | 2.66e-04 | 4 | 198 | 2 | C1298692 | |
| Disease | testicular cancer (implicated_via_orthology) | 4.42e-04 | 5 | 198 | 2 | DOID:2998 (implicated_via_orthology) | |
| Disease | cardiovascular disease biomarker measurement, ankle brachial index | 4.42e-04 | 5 | 198 | 2 | EFO_0003912, EFO_0005278 | |
| Disease | Squamous cell carcinoma of esophagus | 4.60e-04 | 95 | 198 | 5 | C0279626 | |
| Disease | Small cell carcinoma of lung | 4.78e-04 | 54 | 198 | 4 | C0149925 | |
| Disease | cortical thickness | EYA1 DYSF ATP6AP1L PCDH17 PHLDB1 NEO1 GLI3 PKD1 LNX1 FAT3 LAMC1 TACC2 EBF1 PCDHB16 EGFR EIF4G3 PARD3 TNS1 | 5.41e-04 | 1113 | 198 | 18 | EFO_0004840 |
| Disease | diffuse plaque measurement | VWA8 FSTL4 ATP6AP1L PHF2 PTPRN2 LNX1 SDK2 ANK2 EBF1 EYS AATK FARS2 CNTNAP2 TNS1 | 6.41e-04 | 758 | 198 | 14 | EFO_0010699 |
| Disease | glucagon measurement, glucose tolerance test | 6.60e-04 | 6 | 198 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | Pleocytosis | 6.60e-04 | 6 | 198 | 2 | C0151857 | |
| Disease | eye disease (implicated_via_orthology) | 6.60e-04 | 6 | 198 | 2 | DOID:5614 (implicated_via_orthology) | |
| Disease | Leukocytosis | 6.60e-04 | 6 | 198 | 2 | C0023518 | |
| Disease | Dupuytren Contracture | 8.24e-04 | 108 | 198 | 5 | EFO_0004229 | |
| Disease | branchiootorenal syndrome (implicated_via_orthology) | 9.20e-04 | 7 | 198 | 2 | DOID:14702 (implicated_via_orthology) | |
| Disease | Rectal Neoplasms | 9.20e-04 | 7 | 198 | 2 | C0034885 | |
| Disease | ectodermal dysplasia (is_implicated_in) | 9.20e-04 | 7 | 198 | 2 | DOID:2121 (is_implicated_in) | |
| Disease | Rectal Carcinoma | 9.20e-04 | 7 | 198 | 2 | C0007113 | |
| Disease | retinal detachment | 9.20e-04 | 7 | 198 | 2 | EFO_0005773 | |
| Disease | group XIIB secretory phospholipase A2-like protein measurement | 9.20e-04 | 7 | 198 | 2 | EFO_0801657 | |
| Disease | bilirubin metabolic disorder (biomarker_via_orthology) | 9.20e-04 | 7 | 198 | 2 | DOID:2741 (biomarker_via_orthology) | |
| Disease | Glioblastoma Multiforme | 9.32e-04 | 111 | 198 | 5 | C1621958 | |
| Disease | Malignant neoplasm of breast | DYSF ATP6AP1L NEDD4 BMPR2 HERC2 HOXB13 FN1 ANK2 PCDHB15 TACC2 ZNF365 EGFR CHD5 TNS1 CDH10 TP53BP2 TP73 | 9.75e-04 | 1074 | 198 | 17 | C0006142 |
| Disease | corneal resistance factor | TRAF3IP2 ATP6AP1L NEDD4 GLI3 XYLB HERC2 LNX1 ATG12 LRP6 TNS1 | 9.98e-04 | 451 | 198 | 10 | EFO_0010067 |
| Disease | syndromic X-linked intellectual disability (implicated_via_orthology) | 1.22e-03 | 8 | 198 | 2 | DOID:0060309 (implicated_via_orthology) | |
| Disease | helping behavior measurement | 1.22e-03 | 8 | 198 | 2 | EFO_0008538 | |
| Disease | primary ovarian insufficiency (is_implicated_in) | 1.22e-03 | 8 | 198 | 2 | DOID:5426 (is_implicated_in) | |
| Disease | facial hair thickness measurement | 1.28e-03 | 32 | 198 | 3 | EFO_0007823 | |
| Disease | vitamin B12 measurement | 1.28e-03 | 32 | 198 | 3 | EFO_0004620 | |
| Disease | blood nickel measurement | 1.32e-03 | 120 | 198 | 5 | EFO_0007583 | |
| Disease | estrogen-receptor negative breast cancer | 1.35e-03 | 71 | 198 | 4 | EFO_1000650 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.35e-03 | 71 | 198 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | pentachlorophenol measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0022071 | |
| Disease | parathion measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0022070 | |
| Disease | potassium chromate measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0022067 | |
| Disease | methoxychlor measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0022055 | |
| Disease | aldrin measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0022054 | |
| Disease | dicofol measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0022060 | |
| Disease | disulfoton measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0022062 | |
| Disease | dieldrin measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0022061 | |
| Disease | endrin measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0022064 | |
| Disease | endosulfan measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0022063 | |
| Disease | heptachlor measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0022066 | |
| Disease | ethion measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0022056 | |
| Disease | diazinon measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0022058 | |
| Disease | environmental exposure measurement | 1.49e-03 | 73 | 198 | 4 | EFO_0008360 | |
| Disease | isovalerate measurement | 1.56e-03 | 9 | 198 | 2 | EFO_0021051 | |
| Disease | Cleft palate with cleft lip | 1.56e-03 | 9 | 198 | 2 | C0158646 | |
| Disease | DDT metabolite measurement | 1.57e-03 | 74 | 198 | 4 | EFO_0007886 | |
| Disease | endometriosis | 1.63e-03 | 252 | 198 | 7 | EFO_0001065 | |
| Disease | retinal detachment, retinal break | 1.66e-03 | 35 | 198 | 3 | EFO_0005773, EFO_0010698 | |
| Disease | emphysema | 1.66e-03 | 35 | 198 | 3 | EFO_0000464 | |
| Disease | posterior thigh muscle fat infiltration measurement | 1.66e-03 | 35 | 198 | 3 | EFO_0020934 | |
| Disease | reaction time measurement | KLF12 DYSF ATP6AP1L PCDH17 BPI PTPRN2 SPON1 APC TACC2 CEP192 CDH19 EIF4G3 | 1.72e-03 | 658 | 198 | 12 | EFO_0008393 |
| Disease | cortical surface area measurement | SKIDA1 EYA1 DYSF ATP6AP1L SVEP1 NEO1 GLI3 PKD1 LNX1 NOVA1 FAT3 APC LAMC1 CRTAC1 EBF1 EGFR MPHOSPH9 PARD3 TNS1 | 1.86e-03 | 1345 | 198 | 19 | EFO_0010736 |
| Disease | nicotine dependence | 1.90e-03 | 78 | 198 | 4 | EFO_0003768 | |
| Disease | urea measurement | 1.95e-03 | 10 | 198 | 2 | EFO_0011005 | |
| Disease | plasma trimethylamine N-oxide measurement | 1.95e-03 | 10 | 198 | 2 | EFO_0005691 | |
| Disease | dentate gyrus volume measurement | 2.28e-03 | 39 | 198 | 3 | EFO_0010083 | |
| Disease | skin pigmentation measurement | 2.36e-03 | 137 | 198 | 5 | EFO_0007009 | |
| Disease | delta-5 desaturase measurement | 2.37e-03 | 11 | 198 | 2 | EFO_0007764 | |
| Disease | atopic dermatitis (implicated_via_orthology) | 2.37e-03 | 11 | 198 | 2 | DOID:3310 (implicated_via_orthology) | |
| Disease | neuroimaging measurement | SKIDA1 ARHGEF11 DYSF ATP6AP1L NEO1 GLI3 PKD1 LNX1 FAT3 APC LAMC1 TACC2 EGFR TP63 PARD3 TNS1 | 2.41e-03 | 1069 | 198 | 16 | EFO_0004346 |
| Disease | Autism Spectrum Disorders | 2.61e-03 | 85 | 198 | 4 | C1510586 | |
| Disease | myocardial infarction | 2.62e-03 | 350 | 198 | 8 | EFO_0000612 | |
| Disease | interleukin 2 measurement | 2.63e-03 | 41 | 198 | 3 | EFO_0008331 | |
| Disease | Cleft palate, cleft lip | 2.88e-03 | 279 | 198 | 7 | EFO_0003959, HP_0000175 | |
| Disease | serum IgG glycosylation measurement | CPNE8 PXDN GLI3 USH2A TENT2 CACNB1 EYS TMEM132D CNTNAP2 FUT6 | 2.95e-03 | 523 | 198 | 10 | EFO_0005193 |
| Disease | eye color | 3.21e-03 | 90 | 198 | 4 | EFO_0003949 | |
| Disease | social interaction measurement | 3.75e-03 | 94 | 198 | 4 | EFO_0009592 | |
| Disease | brain measurement, neuroimaging measurement | 4.20e-03 | 550 | 198 | 10 | EFO_0004346, EFO_0004464 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 4.44e-03 | 15 | 198 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | response to fenofibrate | 4.63e-03 | 50 | 198 | 3 | GO_1901557 | |
| Disease | blood cobalt measurement | 4.84e-03 | 101 | 198 | 4 | EFO_0007577 | |
| Disease | central corneal thickness | 5.03e-03 | 309 | 198 | 7 | EFO_0005213 | |
| Disease | vision disorder | 5.05e-03 | 16 | 198 | 2 | MONDO_0021084 | |
| Disease | Polyposis, Adenomatous Intestinal | 5.05e-03 | 16 | 198 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 5.05e-03 | 16 | 198 | 2 | C2713443 | |
| Disease | cerebellar volume measurement | 5.17e-03 | 52 | 198 | 3 | EFO_0020864 | |
| Disease | anthropometric measurement | 5.63e-03 | 168 | 198 | 5 | EFO_0004302 | |
| Disease | Adenomatous Polyposis Coli | 5.70e-03 | 17 | 198 | 2 | C0032580 | |
| Disease | urinary bladder cancer (is_marker_for) | 5.93e-03 | 107 | 198 | 4 | DOID:11054 (is_marker_for) | |
| Disease | factor VII measurement | 6.04e-03 | 55 | 198 | 3 | EFO_0004619 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PTSDCYNPAAAVVVT | 356 | Q5U5X8 | |
| DVPSESGSPVYVNQV | 276 | P28222 | |
| VPVSSYQQAGIPVDL | 406 | Q7Z695 | |
| VAFAVRTNVGYNPSP | 101 | Q02641 | |
| VAAVEAPVLPNGSYD | 1001 | Q8TDI0 | |
| VEPGNFIAATSLYSP | 236 | Q02338 | |
| STPAVPQAPVQGEDY | 546 | O95831 | |
| TSVPVLYPGLNASAA | 346 | O14503 | |
| QANGIPGTPISVAYT | 371 | Q9Y6D6 | |
| GLVYEPTVFDLSPQQ | 106 | Q96RQ1 | |
| ITTAIPNTVYPAQGQ | 366 | Q9NZU0 | |
| QQYDAPEPGTQRLST | 576 | O15085 | |
| LTYGNVSPIQTSASP | 56 | Q6PIY7 | |
| QFPSVYAVPGTEQTE | 121 | O75952 | |
| QGSVYEDVPPFTSVL | 821 | Q9HCU4 | |
| VPVYSDSTIQEASPN | 1561 | Q6UB98 | |
| QDVVPQAYSGTPLTE | 41 | Q9H6U6 | |
| PDSAFQVTTGYQLPV | 196 | Q13117 | |
| PDSAFQVTTGYQLPV | 196 | Q9NR90 | |
| AFPAYPNSAVQVTTG | 431 | Q9NR90 | |
| PSRVAAVGPYIQSST | 341 | Q13625 | |
| QSFAPSPDQEVGTLY | 106 | O94817 | |
| PALVVYESQAGQPVQ | 436 | Q969G9 | |
| VVTQPPPAAYSNSES | 1051 | P49792 | |
| NEQSSGPVPETVRSY | 726 | P20742 | |
| VYTVAPNVQRIPTAG | 521 | A0AV96 | |
| SNDNSPVFEAPSYLV | 236 | O14917 | |
| LSVPVSETAYPGQTQ | 81 | Q99504 | |
| PDVGVNSLQSYQLSP | 161 | Q9Y5H2 | |
| PSVYIPEFIAANQSA | 176 | Q9NPH2 | |
| YIATQGPLPATVADF | 816 | Q92932 | |
| YELTQPPSVSVSLGQ | 21 | A0A075B6K0 | |
| YDGSVVAINPESDQP | 171 | P02708 | |
| GPVTEAAIFYETQPS | 16 | P04217 | |
| DPQITSPYENVPSQS | 2921 | Q01484 | |
| PSQPVAFIGQTEYSQ | 1546 | Q8N7Z5 | |
| PVFTYVSINPNSGDI | 501 | Q8TAB3 | |
| PSSNTPVVNVGTVIY | 8641 | Q8WXI7 | |
| GTNAQVTYSLLPPQD | 481 | Q9Y5F0 | |
| PNEDAPVGTAVLYLT | 106 | Q6TGC4 | |
| QRPPGNVDSYNITLS | 311 | P23467 | |
| PQNVSVADSYDPIST | 886 | P10071 | |
| PSDDVTVVYQNGLPV | 71 | Q8NE86 | |
| DTQPTTYAAEAQGPT | 146 | Q96JG8 | |
| ELQPSVQYQEFPTAS | 1841 | Q5T1H1 | |
| GSLQAYTFEEQPTLP | 746 | P46934 | |
| TYEAVELVPAGAPTQ | 461 | Q8NCE2 | |
| VYTGTESTQNGELPP | 46 | O95714 | |
| LLIPSPNATAEVGYN | 4546 | Q15751 | |
| GQDTLVPPVYTVSQA | 396 | Q8NFR9 | |
| QVEQAVQTAPYRSGP | 1776 | Q9UPA5 | |
| YTSPDESPAVVSVNN | 571 | Q8N187 | |
| PDVTFTINGVPYTLS | 321 | P14091 | |
| QSVPPYGVALNSLTT | 291 | Q10570 | |
| APSVQLSYQPSQDGA | 231 | O14498 | |
| GSAPTTVIYEDNQRP | 61 | P01721 | |
| PALAYESVVAQEGSP | 471 | Q9UIW2 | |
| VFYPSIQEDAPVGTS | 1141 | Q9NYQ8 | |
| PAGPITQGTTVSAYV | 141 | Q9Y233 | |
| TNPITPEVDYKGNST | 61 | P22794 | |
| STNATYQLQEPPSGI | 251 | Q99502 | |
| YQLQEPPSGITSQAV | 256 | Q99502 | |
| QYVAPAVPAESLVDG | 76 | Q99550 | |
| NPAYVSSAEDGQPAI | 181 | Q8TBB1 | |
| YPTEEPAPQATNTVG | 1361 | O75581 | |
| SGQATVPAVRYTNPS | 91 | Q92887 | |
| ANPAGYNPSISIVGT | 546 | P23229 | |
| NLEIYEAVTSPQGPA | 521 | Q32M88 | |
| NDNAPEITVTSVYSP | 346 | Q9UN70 | |
| GTNAQVTYSLLPPQD | 481 | Q9UN67 | |
| LYEVQVPENSPVGSL | 246 | Q9Y5E8 | |
| TPFSYSVPGQANEIV | 336 | O95502 | |
| GQVTVTQPYPLAARS | 96 | Q8TE96 | |
| EQASSGSQIPFDPYA | 786 | Q8IZQ8 | |
| YSFLQAVNGLPTVPS | 21 | Q8TAX0 | |
| RNTNVYVSGLPPDIT | 131 | O43719 | |
| SPQENVVFSSSRGPY | 56 | P09630 | |
| SESGSPDYQQQAAVP | 431 | P09923 | |
| PNYQLQVSESVAPGA | 151 | Q9Y5I4 | |
| YELTQLPSVSVSPGQ | 21 | A0A075B6J6 | |
| SESGSPEYRQQSAVP | 431 | P10696 | |
| GTNAQVTYSLLPPQD | 481 | Q9NRJ7 | |
| EPPQVGTEFTTILYN | 241 | O15350 | |
| NVPALESGYTQISPE | 1501 | Q92794 | |
| EPPQVGTEFTTVLYN | 291 | Q9H3D4 | |
| GSVISYPLENAVPFS | 91 | O75787 | |
| TAVGNPEYLNTVQPT | 1131 | P00533 | |
| IYVQEVAPNSPSQRG | 386 | P83110 | |
| NPDVYTLVTGLQPDV | 96 | Q9BXL6 | |
| PDSAFQVTTGYQLPV | 526 | Q9NQZ3 | |
| QPVSYPFTIIGQVAS | 341 | P00156 | |
| PAGTAVTPNYVDNVS | 196 | Q9GZZ7 | |
| VTPNYVDNVSARVAP | 201 | Q9GZZ7 | |
| NPVIYITENGFPQSD | 366 | Q9H227 | |
| SILQGQPYFSVEPET | 201 | Q9Y6N8 | |
| PISAFSQDNIYEVQP | 851 | Q92562 | |
| VSVYAQNPSGESQPL | 1701 | P02751 | |
| INYGLVAPPATTAET | 236 | P17213 | |
| YPESQAQEPGVAASL | 346 | Q6MZW2 | |
| PEIAQVIASYTATGP | 1076 | Q15811 | |
| NFISEAAAAQYTPEP | 46 | Q96L46 | |
| ISAISEAAAQYNPEP | 66 | P04632 | |
| DNSPVFTPANYTAVI | 3441 | Q8TDW7 | |
| NPENPEFNTGYAITV | 171 | Q5T764 | |
| VTTTPPSIQNGTYRF | 101 | Q13873 | |
| AGTITQAPPYAVAAP | 246 | Q9H3Q1 | |
| PGAVVEAQTSVPYAI | 311 | Q8NFZ8 | |
| PAVEYVPSESIGQEQ | 1951 | Q5VT06 | |
| LNGSAANSPYAIVPS | 506 | Q9UH73 | |
| VSQDDPTVYPNGSRF | 36 | P51993 | |
| TYVLQGDPRAVSTQP | 726 | Q99062 | |
| VLSNGVPVSNFTYSP | 916 | P10253 | |
| PALGFSTYSVAQVPR | 571 | O00754 | |
| SEPVTPANINLYAEA | 251 | Q9Y2E5 | |
| TQSNADALPPDYSVV | 86 | Q6UWN5 | |
| AEAAAPYTVLAQSAP | 261 | Q8N2S1 | |
| YPAVAGEPVQNSVAV | 1296 | Q8TEP8 | |
| FVNQINTAVPLPGYT | 326 | Q7Z7F0 | |
| QSVPVVYTAVRSPGN | 191 | Q9Y4X4 | |
| VPLIAQGNSYPSETT | 606 | P11047 | |
| TAVTNSVLPPDYDSN | 36 | Q9NQ79 | |
| VGNLSFSCVEPYTVP | 361 | Q9UHC6 | |
| ESGQVPVYAVTFQEP | 261 | Q8WYP5 | |
| PDSAFQVTTGYQLPV | 361 | Q86SG3 | |
| SYTPQAAARGTTPQE | 801 | Q9C0E4 | |
| AQAATLAAYPAETPT | 101 | Q92826 | |
| DQGNRITPSYVAFTP | 56 | P11021 | |
| YGEPSNPSTAVSAQV | 1986 | Q7Z5N4 | |
| NPSTAVSAQVEAPFY | 1991 | Q7Z5N4 | |
| FTYGPEIEANVTTGP | 1806 | Q58EX2 | |
| QPTGASLVLQVSYTP | 111 | O75923 | |
| IRPGAQTPTAVYQAN | 31 | O43432 | |
| LQGQPYFSVEPTTGV | 191 | Q9H159 | |
| SVQLYGPTNFAPVIN | 406 | Q86YQ8 | |
| TPEYGSILVPNVDNV | 2556 | Q8TE73 | |
| AFASTVPGLYNVNSP | 46 | P31268 | |
| PTQPDARLTAYVTGN | 1306 | P98161 | |
| GTNAQVTYSLLPPQD | 481 | Q9Y5E6 | |
| FQPYQATSEIEVTPS | 116 | Q8TEW0 | |
| PYANTAEVLPTAAAA | 271 | P51513 | |
| GTNAQVTYSLLPPQD | 481 | Q9Y5E1 | |
| AVQGSAVEVQTYQPP | 286 | Q96A47 | |
| YPSTGQETAPEVNFT | 76 | Q9BS40 | |
| PEELNTSVYQPIDGS | 26 | Q96HJ5 | |
| TTPDYSPQEAFTNAI | 76 | Q9H1A7 | |
| LEGQVYTNTSPPNLS | 476 | Q8N2Y8 | |
| PQNPFYLETGVTGTA | 871 | A6NKG5 | |
| TSPSNPNGVVTEYSI | 3041 | O75445 | |
| QSPFYDPEGGSITQV | 386 | Q9HCB6 | |
| DGAPVQPSQVEYTAD | 346 | Q12872 | |
| ETQNATTIPPYNPVD | 411 | Q96M34 | |
| SEEVGALEYNPSSQP | 771 | O75151 | |
| DSENATVLPPIGYQA | 2161 | Q8WUY3 | |
| PVLNASYGPFSIEQV | 91 | Q14C87 | |
| SYGPFSIEQVVPQDL | 96 | Q14C87 | |
| SVVAYNNLIESPPAF | 221 | Q96BN2 | |
| SPATAAQNGPDVYVL | 81 | Q6ZMQ8 | |
| QFYDRVSLSVQPGPT | 321 | Q8NHL6 | |
| YELTQPSSVSVSPGQ | 21 | P01718 | |
| SAQELPQVEAYSPSA | 581 | Q14934 | |
| PVTNSEVALVNAYPE | 111 | Q8WWF3 | |
| AQVIIPSTYVPGTTN | 286 | P08709 | |
| PSYTEPQNLTGVSEF | 16 | Q6IFN5 | |
| SQPEPSSVYAGNNAI | 156 | Q92859 | |
| ETAPLQGNYVAFPSD | 196 | Q1XH10 | |
| PASNASIYTGVIIVP | 466 | Q9H2Y9 | |
| APTGEAPTYVNTQQI | 416 | Q92529 | |
| SPQRSTSGYPLQEVV | 21 | P0DUX0 | |
| SPQRSTSGYPLQEVV | 21 | P0DTA3 | |
| SPQRSTSGYPLQEVV | 21 | P0DUD1 | |
| VSYPPQNLTVTVFQG | 236 | Q9Y286 | |
| TVEAEYPFNQSPVVT | 56 | P55000 | |
| YNFGLQETPQSRPSV | 31 | O15457 | |
| SLSQSFPPQYQEAVE | 581 | Q9UHV7 | |
| TPFSYAVPGQANEIV | 266 | P47972 | |
| PQGETIVQYTATDPS | 696 | Q4LDE5 | |
| VPESTYTSIQGDPQR | 336 | Q9NWQ8 | |
| ELIVNGSYTPQTVPT | 181 | O15047 | |
| SPQRSTSGYPLQEVV | 31 | A6NHP3 | |
| SAAQVAVQDPSLPVY | 491 | O94993 | |
| FPGNYVAPVTRAVTN | 496 | Q7Z6J0 | |
| TVAARVTPFNYNPSP | 2776 | P25054 | |
| RPSYQANDVTGVQLP | 516 | Q0VFZ6 | |
| LPTIDTGYDSQPQDV | 201 | O43734 | |
| TTPDYSPQEAFTNAI | 76 | Q9GZM3 | |
| ATQNIPPGSTAYVTG | 296 | O60235 | |
| GSLPSAYQFVRDPQS | 841 | O15417 | |
| QYTPEGQNPSSATVL | 191 | Q8N413 | |
| YISLPGVVFSPQVSQ | 241 | Q9UNN4 | |
| SPQRSTSGYPLQEVV | 21 | P0DUX1 | |
| SPQRSTSGYPLQEVV | 21 | A0A494C0Z2 | |
| SPQRSTSGYPLQEVV | 21 | P0DUD3 | |
| SPQRSTSGYPLQEVV | 21 | P0DUD4 | |
| SPQRSTSGYPLQEVV | 21 | P0DUD2 | |
| SPQRSTSGYPLQEVV | 31 | A0A494C086 | |
| SPQRSTSGYPLQEVV | 31 | Q495Y8 | |
| SPQRSTSGYPLQEVV | 31 | A6NIY4 | |
| SPQRSTSGYPLQEVV | 31 | P0CI01 | |
| GQYENQSPEATSPRS | 901 | Q9HBL0 | |
| YENPGVFSPAQLTQI | 1251 | Q92626 | |
| LAATPSPGASQVYEA | 501 | O75191 | |
| VSAGSPPIRNVTVAY | 36 | Q9Y6I9 | |
| GSQAASVITYTAPPR | 501 | Q9P1Z0 | |
| NGQLIYTPFTEDTPS | 116 | P49810 | |
| ELSEPGNTYEQIPAT | 411 | A6NKC9 | |
| GDAVQTPQLYTTFLP | 671 | Q9H3T2 | |
| STPYQEIAAVPSAGR | 161 | O95359 | |
| SITPYITGVFPNSVI | 1746 | Q86WI1 | |
| YSPVPAESESLVNGN | 156 | Q86UU1 | |
| AVPGTPQYVDEQFLS | 161 | Q96GF1 | |
| SIYPVSSTVQPVAAA | 226 | Q96KR1 | |
| PVAAAATVVPSYTQS | 236 | Q96KR1 | |
| VFQQGTQQTYEPDSP | 851 | Q86YA3 | |
| TPEISSENRPYQGAV | 601 | Q3KQV3 | |
| SPQRSTSGYPLQEVV | 21 | A0A494C191 | |
| SELITAPPYAGVSIQ | 116 | Q70YC4 | |
| APPYAGVSIQGFSQI | 121 | Q70YC4 | |
| SLVEVNPAYSVPSSQ | 266 | A0AVI4 | |
| YVVNGDNTPSSPSQV | 206 | Q9H0M0 | |
| PPQTSGYIEVTDLQS | 1446 | A3KMH1 | |
| GTPLFSVYDNLSPVV | 106 | O95363 | |
| ISPDRNSVPQEGQYS | 221 | Q69YN4 | |
| SIQAVFNPTGVYAPS | 71 | Q52LC2 | |
| AVPYQGPQLTSTSLA | 1461 | P15822 | |
| LTYSTFVPLQAGPVQ | 2411 | P15822 | |
| SIGTQYSANPPVTID | 111 | O94842 | |
| VTQAPISARAGPVYS | 961 | O43156 | |
| TLSPGDYIFVDPTQQ | 296 | P57075 | |
| DGQQEPQPFVTSDVY | 201 | Q6NSJ0 | |
| SGQVEVNITEFPYTP | 326 | Q15223 |